| Over a month ago |
|
Hot Stocks
|
In a regulatory filing,… In a regulatory filing, New York Times disclosed that its CEO Meredith Kopit Levien sold 29.8K shares of common stock on February 17th in a total transaction size of $1.19M. ShowHide Related Items >><< - 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 02/09/23 Morgan Stanley
- New York Times price target raised to $40 from $37 at Morgan Stanley
- 02/09/23 Barclays
- New York Times upgraded to Equal Weight from Underweight at Barclays
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 12/16/22
- Twitter suspends journalists covering Musk, company, NBC News reports
- 12/09/22
- New York Times staffers went on strike Thursday, WSJ reports
- 10/20/22
- New York Times halts plans for children's app, WSJ reports
- 09/13/22
- Union members of New York Times, NBC News defy return-to-office, WSJ reports
- 02/09/23
- What You Missed On Wall Street On Thursday
- 02/09/23
- What You Missed On Wall Street This Morning
- 02/09/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/08/23
- What You Missed On Wall Street On Wednesday
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 01/31/23
- Exxon Mobil reports Q4 cash flow from operating activities $18.95B
- 01/30/23
- Exxon Mobil awards FEED for world's largest low-carbon hydrogen facility
- 01/24/23
- Exxon Mobil trading resumes
- 01/24/23
- Exxon Mobil trading halted, volatility trading pause
- 01/10/23
- Veru appoints David Ho as chairman of Scientific Advisory Board
- 11/09/22
- Veru announces update on FDA AdCom meeting on Sabizabulin as COVID treatment
- 11/09/22
- Veru trading halted, news pending
- 11/07/22
- Veru jumps 32% after FDA posts briefing documents for meeting of advisors
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 09/09/22
- Tapestry announces long-term financial targets
- $20.80 /
+2.945 (+16.49%) - 11/16/22
- Sonos authorizes up to $100M stock buyback
- 11/16/22
- Sonos names Eddie Lazarus CFO
- 09/09/22
- USITC institutes investigation of Sonos audio players after Google complaint
- 08/10/22
- Sonos drops 20% to $18.18 after cutting FY22 guidance, CFO change
- 02/01/23
- Rapid7 trading resumes
- 02/01/23
- Rapid7 trading halted, volatility trading pause
- 09/22/22
- Rapid7 enters multi-year partnership with The Bruins
- 01/19/23
- Purple Innovation special committee comments on Capital Management filing
- 01/12/23
- Purple Innovation rejects unsolicited proposal from Coliseum Capital Management
- 12/15/22
- AWH Capital urges Purple Innovation to reject Coliseum's takeover offer
- 11/03/22
- Lovesac appoints John Legg as CSCO
- 02/08/23
- Post Holdings to acquire select pet food brands from J.M. Smucker for $1.2B
- 02/08/23
- J.M. Smucker to sell several pet food brands to Post Holdings for $1.2B
- 02/02/23
- Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 02/09/23
- PepsiCo sees FY23 share repurchases approximating $1B
- 02/09/23
- PepsiCo focused on delivering at least $1B in productivity savings
- 02/09/23
- PepsiCo: Monitoring consumers' spending patterns, behaviors
- 02/09/23
- PepsiCo expects inflationary pressures to persist
- 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- 02/09/23
- Globus Medical, NuVasive to combine in all-stock transaction
- 02/09/23
- Globus Medical, NuVasive to combine in all-stock transaction
- 12/19/22
- CubeSmart to replace NuVasive in S&P 400 at open on 12/19
- 12/19/22
- NuVasive to replace Tupperware Brands in S&P 600 at open on 12/19
- 11/07/22
- 23andMe presents poster for expansion chohorts for 23ME-00610
- 10/27/22
- 23andMe granted FDA 510(k) clearance for PGt report for SLCO1B1
- 09/19/22
- 23andMe appoints Daniel Chu as CPO
- 08/19/22
- 23andMe CFO Steven Schoch to step down
- 02/08/23
- Medtronic announces late-breaking clinical data from STROKE AF trial
- 01/30/23
- Medtronic recalls Hemodialysis Catheters for leaks, FDA says
- 01/27/23
- Orchestra BioMed begins trading on Nasdaq with cash runway into 2026
- 01/25/23
- Medtronic recommends rejection of below-market mini-tender by TRC Capital
- 02/08/23
- Mattel CEO: Our products are in demand and our business fundamentals are strong
- 02/08/23
- Mattel sees FY23 capex $175M-$200M vs. $187M in FY22
- 02/08/23
- Mattel says gross margins impacted by higher costs to manage inventory
- 02/08/23
- Mattel falls 10% to $18.50 after Q4 earnings miss, below-consensus guidance
- 02/06/23
- Southwest Dispatchers and Facilities Maintenance Technicians approve CBAs
- 02/01/23
- Southwest promotes Lauren Woods to chief information officer
- 01/26/23
- Southwest says it continues to experience year-over-year inflationary pressures
- 01/26/23
- Southwest plans to add 7,000 workers in 2023
- 02/09/23
- Kellogg sees FY23 tax rate 22%
- 02/09/23
- Kellogg working towards N.A. cereal spin-off, to retain plant-based business
- 02/09/23
- Kellogg CEO says entering 2023 in solid financial condition
- 01/30/23
- Colgate-Palmolive names Steve Cahillane to Board of Directors
- 12/05/22
- Hims & Hers names Scott Knoer as 1st Chief Pharmacy & Innovation Officer
- 11/15/22
- Amazon announces 'Amazon Clinic' virtual health service
- 11/08/22
- Hims & Hers rises 26.0%
- 11/08/22
- Hims & Hers rises 20.1%
- $62.98 /
-14.14 (-18.34%) - 02/09/23
- Globus Medical falls -17.3%
- 02/09/23
- Globus Medical falls -14.5%
- 02/09/23
- Globus Medical falls -14.9%
- 01/31/23
- Nevada reports December statewide gaming win up 14.3% to $1.31B
- 01/30/23
- Bragg Gaming launches new content with DraftKings in New Jersey
- 12/30/22
- DraftKings to launch online sportsbook in Ohio on New Year's Day
- 12/29/22
- Cathie Wood's ARK Investment bought 137K shares of DraftKings today
- $110.34 /
-1.435 (-1.28%) - 02/09/23
- Disney announces details of strategic restructuring
- 02/09/23
- Disney 'pleased' board can remain focused without proxy contest distraction
- 02/09/23
- Trian concludes proxy campaign with Disney, withdraws Peltz nomination
- 02/09/23
- Nelson Peltz says 'proxy fight is over' with Disney after last night's report
- 02/09/23
- DHT Holdings rises 13.5%
- 01/09/23
- DHT Holdings:Q4 time charter equivalent fleet earnings ~ $56,900 per day
- 09/08/22
- DHT Holdings announces new dividend policy
- 08/29/22
- DHT Holdings announces sale of DHT Edelweiss
CSII Cardiovascular Systems - 02/08/23
- Cardiovascular Systems trading resumes
- 02/08/23
- Cardiovascular Systems trading halted, news pending
- 02/09/23
- Credit Suisse announces acquisition of The Klein Group LLC for $175M
- 02/09/23
- Credit Suisse warns of 'substantial loss before taxes' for 2023
- 02/09/23
- Credit Suisse expects to report a loss for WM, IB in Q1
- 02/09/23
- Credit Suisse: Cost transformation 'well under way'
- 02/08/23
- Salesforce CEO teases AI efforts, says 'get ready to be wowed' by EinsteinGPT
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/22/23
- Fly Intel: Top five weekend stock stories
- 01/12/23
- Walmart enters partnership with Salesforce to provide solutions for retailers
- $12.33 /
-3.865 (-23.87%) - 10/05/22
- Digital Turbine announces investment in Aptoide app store
- $16.11 /
+3.425 (+27.00%) - 02/08/23
- AppLovin jumps 28% to $16.18 after Q4 results and guidance
- 11/30/22
- AppLovin exec sells $17.6M in common stock
- 11/29/22
- AppLovin CMO Jansen sells 48,562 class A shares
- 11/09/22
- AppLovin says 'uniquely positioned to emerge from downturn'
- 11/09/22
- Adidas sees 'strong' bottomline improvement in 2023
- 11/09/22
- Adidas sees FY22 currency-neutral revenue up at a low single digit rate
- 11/08/22
- Adidas names Bjorn Gulden as new CEO, effective January 1, 2023
- 11/04/22
- Adidas confirms talks with Gulden as potential successor to CEO
- 02/06/23
- Cathie Wood's ARK Investment bought 313.7K shares of Accolade today
- $108.06 /
-2.175 (-1.97%) - 02/08/23
- Cardiovascular Systems jumps 43% after announcing it is being acquired by Abbott
- 02/08/23
- Abbott to acquire Cardiovascular Systems for $20 per share, or $890M
- 01/26/23
- Abbott: FDA approves Proclaim XR spinal cord stimulation system
- 01/25/23
- Abbott expects $2B in covid testing in FY23
- 02/09/23
- AbbVie says 'high level of confidence' in achieving FY23 guidance
- 02/09/23
- AbbVie expects inflation to weigh on aesthetics business in 2023
- 02/09/23
- AbbVie says breadth, depth of pipeline supports long term growth outlook
- 02/09/23
- AbbVie reports Q4 global Humira net revenues $5.58B, up 4.6% on reported basis
- $150.95 /
-0.995 (-0.65%) - 02/02/23
- Apple pares decline during Q1 conference call, now down 1% at $149.35 afterhours
- 02/02/23
- Apple CFO says 'doing a lot of work on cost structure' to help gross margin
- 02/02/23
- Apple CFO says y/y performance of Q2 to be similar to Q1
- 02/02/23
- Apple CFO Maestri says customer satisfaction for iPhone 14 at 98%
- $110.34 /
-1.435 (-1.28%) - 02/09/23 Loop Capital
- Disney price target raised to $130 from $120 at Loop Capital
- 02/09/23 BofA
- Disney price target raised to $135 from $115 at BofA
- 02/09/23 KeyBanc
- Disney price target raised to $130 from $119 at KeyBanc
- 02/09/23 Credit Suisse
- Disney price target raised to $133 from $126 at Credit Suisse
- $108.06 /
-2.175 (-1.97%) - 02/09/23 Lake Street
- Cardiovascular Systems downgraded to Sell from Buy at Lake Street
- 02/07/23 Needham
- Surmodics price target lowered to $34 from $46 at Needham
- 01/27/23 Barclays
- Abbott price target raised to $125 from $122 at Barclays
- 01/26/23 Piper Sandler
- Abbott approval 'incremental headwind' to Nevro, says Piper Sandler
CSII Cardiovascular Systems - 12/21/22 Barclays
- Cardiovascular Systems initiated with an Equal Weight at Barclays
- 12/14/22 Lake Street
- Cardiovascular Systems initiated with a Buy at Lake Street
- 03/02/22 BofA
- Cardiovascular Systems reinstated with an Underperform at BofA
- 12/20/22 Atlantic Equities
- Coca-Cola, Pepsi remain preferred beverage names at Atlantic Equities
- 12/07/22 Argus
- PepsiCo price target raised to $206 from $195 at Argus
- 12/06/22 Deutsche Bank
- PepsiCo price target raised to $186 from $181 at Deutsche Bank
- 11/04/22 Redburn
- PepsiCo initiated with a Sell at Redburn
- 02/09/23 UBS
- J.M. Smucker upgraded to Neutral from Sell at UBS
- 02/07/23 Barclays
- Post Holdings price target raised to $105 from $102 at Barclays
- 02/06/23 Truist
- Post Holdings price target raised to $85 from $70 at Truist
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 02/10/23 Wells Fargo
- Globus Medical downgraded to Equal Weight from Overweight at Wells Fargo
- 02/10/23 Wells Fargo
- NuVasive downgraded to Equal Weight from Overweight at Wells Fargo
- 02/10/23 Needham
- Needham downgrades Globus on 'meaningful' integration risks
- 02/10/23 Truist
- NuVasive downgraded to Hold from Buy at Truist
- $62.98 /
-14.14 (-18.34%) - 02/09/23 Roth MKM
- Roth MKM downgrades DraftKings to Sell with $15 price target
- 02/09/23 Roth MKM
- DraftKings downgraded to Sell from Neutral at Roth MKM
- 02/01/23 Piper Sandler
- DraftKings layoffs should be viewed positively, says Piper Sandler
- 01/23/23 Stifel
- DraftKings initiated with a Hold at Stifel
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy at Jefferies ahead of FY23 guidance
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy from Hold at Jefferies
- 01/10/23 Tigress Financial
- Hims & Hers price target raised to $12 from $11 at Tigress Financial
- 01/03/23 Piper Sandler
- Hims & Hers price target raised to $7 from $6 at Piper Sandler
- 02/09/23 Jefferies
- Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results
- 02/09/23 Jefferies
- Accolade downgraded to Hold from Buy at Jefferies
- 02/02/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/01/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/09/23 Canaccord
- Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook
- 02/09/23 Mizuho
- Rapid7 price target raised to $45 from $40 at Mizuho
- 02/09/23 Baird
- Rapid7 price target lowered to $56 from $58 at Baird
- 02/09/23 Raymond James
- Rapid7 price target raised to $55 from $50 at Raymond James
- 02/09/23 Morgan Stanley
- New York Times price target raised to $40 from $37 at Morgan Stanley
- 02/09/23 Barclays
- New York Times upgraded to Equal Weight from Underweight at Barclays
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 02/01/23 Deutsche Bank
- Salesforce evaluating value options, shares have 35% upside, says Deutsche
- 01/30/23 Morgan Stanley
- Salesforce price target raised to $236 from $228 at Morgan Stanley
- 01/27/23 BMO Capital
- SAP price target raised to $125 from $110 at BMO Capital
- 01/23/23 Deutsche Bank
- Salesforce price target lowered to $190 from $200 at Deutsche Bank
- 02/08/23 Redburn
- Southwest downgraded to Neutral from Buy at Redburn
- 01/27/23 Deutsche Bank
- Southwest price target lowered to $52 from $56 at Deutsche Bank
- 01/27/23 TD Cowen
- Southwest price target lowered to $50 from $55 at Cowen
- 01/12/23 Barclays
- Southwest price target lowered to $42 from $48 at Barclays
- $150.95 /
-0.995 (-0.65%) - 02/07/23 Craig-Hallum
- Skyworks price target raised to $130 from $120 at Craig-Hallum
- 02/07/23 Credit Suisse
- Skyworks price target raised to $135 from $125 at Credit Suisse
- 02/07/23 KeyBanc
- Skyworks price target raised to $130 from $120 at KeyBanc
- 02/06/23 Credit Suisse
- Credit Suisse reiterates Outperform on Dell Technologies after 5% headcount cut
- 01/31/23 Bernstein
- Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
- 01/24/23 Mizuho
- Medtronic price target lowered to $95 from $100 at Mizuho
- 01/09/23 RBC Capital
- Medtronic downgraded to Sector Perform from Outperform at RBC Capital
- 11/30/22 Wells Fargo
- Medtronic price target lowered to $77 from $82 at Wells Fargo
- 02/02/23 Argus
- Exxon Mobil price target raised to $133 from $128 at Argus
- 02/02/23 TD Cowen
- Exxon Mobil price target raised to $113 from $108 at Cowen
- 02/01/23 Truist
- Exxon Mobil price target raised to $110 from $101 at Truist
- 02/01/23 BofA
- Exxon Mobil price target raised to $140 from $136 at BofA
- 01/27/23 Morgan Stanley
- Credit Suisse resumed with an Equal Weight at Morgan Stanley
- 01/13/23 Barclays
- Credit Suisse price target lowered to CHF 2.90 from CHF 4 at Barclays
- 01/13/23 Deutsche Bank
- Credit Suisse reinstated with a Hold at Deutsche Bank
- 12/20/22 Exane BNP Paribas
- Credit Suisse resumed with an Underperform at Exane BNP Paribas
- $16.11 /
+3.425 (+27.00%) - 02/09/23 Morgan Stanley
- AppLovin signs of stability 'count as a win,' says Morgan Stanley
- 02/08/23 Credit Suisse
- AppLovin price target lowered to $47 from $57 at Credit Suisse
- 02/06/23 KeyBanc
- AppLovin price target lowered to $20 from $25 at KeyBanc
- 01/27/23 DA Davidson
- Playtika cut to Neutral at DA Davidson on market share loss, Rovio offer
- $20.80 /
+2.945 (+16.49%) - 10/17/22 Morgan Stanley
- Sonos price target lowered to $17 from $20 at Morgan Stanley
- 08/11/22 Morgan Stanley
- Sonos price target lowered to $20 from $28 at Morgan Stanley
- 08/11/22 Stifel
- Sonos price target lowered to $20 from $24 at Stifel
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures
- 11/29/22 Jefferies
- DHT Holdings price target raised to $12 from $11 at Jefferies
- 07/20/22 Jefferies
- DHT Holdings initiated with a Buy at Jefferies
- 07/19/22 Stifel
- DHT Holdings price target raised to $8.50 from $7.50 at Stifel
- 04/27/22 Jefferies
- DHT Holdings reinstated with a Buy at Jefferies
- 11/28/22 Berenberg
- Berenberg starts 'well-positioned' 23andMe with a Buy
- 11/28/22 Berenberg
- 23andMe initiated with a Buy at Berenberg
- 09/22/22 TD Cowen
- 23andMe initiated with Outperform, $6 target at Cowen
- 09/22/22 TD Cowen
- 23andMe initiated with an Outperform at Cowen
- $12.33 /
-3.865 (-23.87%) - 02/09/23 Craig-Hallum
- Digital Turbine price target lowered to $25 from $30 at Craig-Hallum
- 02/09/23 Oppenheimer
- Oppenheimer downgrades Digital Turbine on 'unclear' long-term growth
- 02/09/23 Oppenheimer
- Digital Turbine downgraded to Perform from Outperform at Oppenheimer
- 02/01/23 B. Riley
- B. Riley downgrades Digital Turbine on app economy softness
- 02/10/23 H.C. Wainwright
- Veru price target lowered to $14 from $18 at H.C. Wainwright
- 12/07/22 H.C. Wainwright
- Veru price target lowered to $18 from $21 at H.C. Wainwright
- 11/10/22 H.C. Wainwright
- Veru price target lowered to $21 from $24 at H.C. Wainwright
- 09/20/22 Oppenheimer
- Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged'
- 01/16/23 BofA
- Purple Innovation reinstated with an Underperform at BofA
- 11/10/22 Craig-Hallum
- Purple Innovation upgraded to Buy from Hold at Craig-Hallum
- 09/20/22 Craig-Hallum
- Purple Board likely to reject Coliseum's deal, says Craig-Hallum
- 09/20/22 Wedbush
- Purple Innovation price target raised to $5 from $3.30 at Wedbush
- 02/10/23 Morgan Stanley
- Tapestry assumed with an Equal Weight at Morgan Stanley
- 02/10/23 Baird
- Tapestry price target raised to $52 from $45 at Baird
- 01/23/23 Barclays
- Capri Holdings price target raised to $72 from $56 at Barclays
- 01/23/23 Barclays
- Tapestry downgraded to Equal Weight from Overweight at Barclays
- 02/10/23 SVB Securities
- AbbVie upgraded to Market Perform from Underperform at SVB Securities
- 02/10/23 SVB Securities
- AbbVie upgraded to Market Perform from Underperform at SVB Securities
- 02/09/23 Piper Sandler
- AbbVie price target raised to $163 from $157 at Piper Sandler
- 02/08/23 Truist
- Model N price target raised to $52 from $45 at Truist
- 01/30/23 Deutsche Bank
- Kellogg price target lowered to $72 from $74 at Deutsche Bank
- 12/20/22 Morgan Stanley
- Kellogg price target raised to $74 from $72 at Morgan Stanley
- 11/15/22 Exane BNP Paribas
- Kellogg initiated with an Underperform at Exane BNP Paribas
- 08/08/22 RBC Capital
- Kellogg price target raised to $70 from $66 at RBC Capital
- 02/10/23 BMO Capital
- Mattel price target lowered to $27 from $30 at BMO Capital
- 02/10/23 BofA
- Mattel price target lowered to $21 from $26 at BofA
- 02/09/23 DA Davidson
- Mattel price target lowered to $23 from $31 at DA Davidson
- 01/31/23 Goldman Sachs
- Mattel assumed with a Buy at Goldman Sachs
- 02/10/23 Jefferies
- Adidas downgraded to Hold from Buy at Jefferies
- 02/03/23 Deutsche Bank
- Adidas price target raised to EUR 170 from EUR 160 at Deutsche Bank
- 01/26/23 Credit Suisse
- Adidas price target raised to EUR 103 from EUR 83 at Credit Suisse
- 01/23/23 TD Cowen
- Skechers upgraded to Outperform at Cowen on momentum and margin recovery
- 01/31/23
- Exxon Mobil reports Q4 adjusted EPS $3.40, consensus $3.29
- 01/30/23
- Notable companies reporting before tomorrow's open
- 10/28/22
- Exxon Mobil reports Q3 adjusted EPS $4.45, consensus $3.79
- 02/09/23
- Veru reports Q1 EPS (46c), consensus (38c)
- 12/05/22
- Veru reports Q4 EPS (51c), consensus (30c)
- 08/11/22
- Veru reports Q3 EPS (28c), consensus (18c)
- 02/09/23
- Tapestry raises FY23 EPS view to $3.70-$3.75 from $3.60-$3.70, consensus $3.65
- 02/09/23
- Tapestry reports Q2 EPS $1.36, consensus $1.27
- $20.80 /
+2.945 (+16.49%) - 02/08/23
- Sonos affirms FY23 revenue view of $1.7B-$1.8B, consensus $1.73B
- 02/08/23
- Sonos reports Q1 EPS 79c, consensus 40c
- 11/16/22
- Sonos sees FY23 revenue $1.7B-$1.8B, consensus $1.72B
- 11/16/22
- Sonos reports Q4 adjusted EPS (32c), consensus (41c)
- 02/08/23
- Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c
- 02/08/23
- Rapid7 sees Q1 EPS 7c-10c, consensus 7c
- 02/08/23
- Rapid7 reports Q4 EPS 35c, consensus 18c
- 11/02/22
- Rapid7 sees FY22 EPS 17c-20c, consensus 11c
- 01/30/23
- Purple Innovation sees FY22 net loss ($97.5M)-($83.7M)
- 11/09/22
- Purple Innovation backs FY22 revenue view $570M-$590M, consensus $578.66M
- 11/09/22
- Purple Innovation reports Q3 adjusted EPS 3c, consensus (5c)
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
- 02/09/23
- PepsiCo sees FY23 core EPS $7.20, consensus $7.28
- 02/09/23
- PepsiCo sees FY23 core EPS growth 8%, consensus $7.28
- 02/09/23
- PepsiCo reports Q4 core EPS $1.67, consensus $1.65
- 02/08/23
- Notable companies reporting before tomorrow's open
- 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 02/09/23
- NuVasive sees FY23 net sales growth 6%-8%, consensus $1.28B
- 02/09/23
- NuVasive sees FY22 net sales growth 5.5%, consensus $1.21B
- 11/09/22
- NuVasive lowers FY22 non-GAAP EPS to $2.00-$2.10 from $2.15-$2.45
- 11/09/22
- NuVasive reports Q3 non-GAAP EPS 54c, consensus 54c
- 02/08/23
- 23andMe sees FY23 revenue $290M-$300M, consensus $276.59M
- 02/08/23
- 23andMe reports Q3 EPS (20c), consensus (19c)
- 11/07/22
- 23andMe sees FY23 revenue $260M-$280M, consensus $277.86M
- 11/07/22
- 23andMe reports Q2 EPS (15c), consensus (17c)
- 11/22/22
- Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40
- 11/22/22
- Medtronic says guidance assumes 2H23 reported revenue $15.4B-$15.6B
- 11/22/22
- Medtronic cuts FY23 EPS view to $5.25-$5.30 from $5.53-$5.65, consensus $5.53
- 11/22/22
- Medtronic reports Q2 EPS $1.30, consensus $1.28
- 02/08/23
- Mattel sees FY23 adjusted EPS $1.10-$1.20, consensus $1.66
- 02/08/23
- Mattel reports Q4 adjusted EPS 18c, consensus 29c
- 10/25/22
- Mattel cuts FY22 EPS view to $1.32-$1.42 from $1.42-$1.48
- 01/26/23
- Southwest sees Q1 revenue up 20%-24%, consensus $5.88B
- 01/26/23
- Southwest reports Q4 adjusted EPS (38c), consensus (9c)
- 01/25/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Kellogg sees FY23 EPS down 4% to down 2% on currency neutral basis
- 02/09/23
- Kellogg reports Q4 adjusted currency-neutral EPS 97c, consensus 84c
- 11/07/22
- Hims & Hers raises FY22 revenue view $519M-$522M from $470M-$485M
- 11/07/22
- Hims & Hers sees Q4 revenue $159M-$162M, consensus $134.3M
- 11/07/22
- Hims & Hers reports Q3 EPS (9c), consensus (10c)
- $62.98 /
-14.14 (-18.34%) - 02/09/23
- Globus Medical sees FY23 net sales growth 7%-8%, consensus $1.12B
- 02/09/23
- Globus Medical sees FY22 net sales growth 6.8%, consensus $1.03B
- 11/08/22
- Globus Medical sees FY22 EPS $2.03-$2.10, consensus $2.10
- 11/08/22
- Globus Medical reports Q3 EPS 50c, consensus 52c
- 11/04/22
- DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B
- 11/04/22
- DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B
- 11/04/22
- DraftKings reports Q3 revenue $502M, consensus $437.23M
- 11/03/22
- Notable companies reporting before tomorrow's open
- $110.34 /
-1.435 (-1.28%) - 02/08/23
- Disney reports Q1 EPS ex-items 99c, consensus 78c
- 02/08/23
- Notable companies reporting after market close
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- 02/08/23
- DHT Holdings reports Q4 EPS 38c, consensus 30c
- 11/07/22
- DHT Holdings reports Q3 EPS 4c, consensus (1c)
- 08/10/22
- DHT Holdings reports Q2 EPS 6c, consensus (4c)
CSII Cardiovascular Systems - 02/08/23
- Cardiovascular Systems reports Q2 EPS (20c), consensus (15c)
- 11/03/22
- Cardiovascular Systems sees FY22 revenue $255M-$265M, consensus $258.48M
- 11/03/22
- Cardiovascular Systems reports Q1 EPS (27c), consensus (23c)
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 11/30/22
- Salesforce raises FY23 EPS view to $4.92-$4.94, consensus $4.73
- 11/30/22
- Salesforce sees Q4 EPS $1.35-$1.37, consensus $1.34
- 11/30/22
- Salesforce reports Q3 EPS $1.40, consensus $1.21
- 11/30/22
- Notable companies reporting after market close
- $12.33 /
-3.865 (-23.87%) - 02/08/23
- Digital Turbine sees FY23 adjusted EPS $1.15-$1.20, consensus $1.41
- 02/08/23
- Digital Turbine reports Q3 adjusted EPS 29c, consensus 37c
- 11/09/22
- Digital Turbine sees Q3 adjusted EPS 36c-39c, consensus 38c
- 11/09/22
- Digital Turbine reports Q2 non-GAAP EPS 34c, consensus 33c
- $16.11 /
+3.425 (+27.00%) - 02/08/23
- AppLovin sees Q1 revenue $685M-$705M, consensus $682.2M
- 02/08/23
- AppLovin reports Q4 adjusted EBITDA up 17% at $260M
- 11/09/22
- AppLovin cuts FY22 revenue view from $2.84B-$3.14B to $2.80B-$2.81B
- 02/09/23
- Adidas reports preliminary 2022 sales up 1% in currency-neutral terms
- 02/09/23
- Adidas sees 2023 currency-neutral sales down high-single-digits
- 11/09/22
- Adidas reports Q3 revenue EUR 6.41B vs. EUR 5.752B last year
- 10/20/22
- Adidas now expects FY22 currency neutral revenue up at mid single digit rate
- 01/09/23
- Accolade guides initial FY24 revenue around $410M, consensus $405.4M
- 01/09/23
- Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M
- 01/09/23
- Accolade sees Q4 revenue $97M-$101M, consensus $101.7M
- 01/09/23
- Accolade reports Q3 EPS (56c), consensus (62c)
- $108.06 /
-2.175 (-1.97%) - 01/25/23
- Abbott sees FY23 adjusted EPS $4.30-$4.50, consensus $4.40
- 01/25/23
- Abbott reports Q4 adjusted EPS $1.03, consensus 92c
- 01/24/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08
- 02/09/23
- AbbVie sees FY23 revenue about $52B, consensus $54.21B
- 02/09/23
- AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65
- 02/09/23
- AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56
- $150.95 /
-0.995 (-0.65%) - 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 01/31/23
- Exxon Mobil reports Q4 cash flow from operating activities $18.95B
- 01/30/23
- Exxon Mobil awards FEED for world's largest low-carbon hydrogen facility
- 01/24/23
- Exxon Mobil trading resumes
- 01/24/23
- Exxon Mobil trading halted, volatility trading pause
- 01/10/23
- Veru appoints David Ho as chairman of Scientific Advisory Board
- 11/09/22
- Veru announces update on FDA AdCom meeting on Sabizabulin as COVID treatment
- 11/09/22
- Veru trading halted, news pending
- 11/07/22
- Veru jumps 32% after FDA posts briefing documents for meeting of advisors
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 09/09/22
- Tapestry announces long-term financial targets
- $21.04 /
+3.185 (+17.84%) - 11/16/22
- Sonos authorizes up to $100M stock buyback
- 11/16/22
- Sonos names Eddie Lazarus CFO
- 09/09/22
- USITC institutes investigation of Sonos audio players after Google complaint
- 08/10/22
- Sonos drops 20% to $18.18 after cutting FY22 guidance, CFO change
- 01/30/23
- Simply Good Foods says Geoff Tanner, named COO, CEO-elect of company
- 11/21/22
- J.M. Smucker CEO says 'organic top-line growth across all of our businesses'
- 02/01/23
- Rapid7 trading resumes
- 02/01/23
- Rapid7 trading halted, volatility trading pause
- 09/22/22
- Rapid7 enters multi-year partnership with The Bruins
- 01/19/23
- Purple Innovation special committee comments on Capital Management filing
- 01/12/23
- Purple Innovation rejects unsolicited proposal from Coliseum Capital Management
- 12/15/22
- AWH Capital urges Purple Innovation to reject Coliseum's takeover offer
- 11/03/22
- Lovesac appoints John Legg as CSCO
- 02/08/23
- Post Holdings to acquire select pet food brands from J.M. Smucker for $1.2B
- 02/08/23
- J.M. Smucker to sell several pet food brands to Post Holdings for $1.2B
- 02/02/23
- Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 02/09/23
- PepsiCo sees FY23 share repurchases approximating $1B
- 02/09/23
- PepsiCo focused on delivering at least $1B in productivity savings
- 02/09/23
- PepsiCo: Monitoring consumers' spending patterns, behaviors
- 02/09/23
- PepsiCo expects inflationary pressures to persist
- 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- 02/09/23
- Globus Medical, NuVasive to combine in all-stock transaction
- 02/09/23
- Globus Medical, NuVasive to combine in all-stock transaction
- 12/19/22
- CubeSmart to replace NuVasive in S&P 400 at open on 12/19
- 12/19/22
- NuVasive to replace Tupperware Brands in S&P 600 at open on 12/19
- 11/07/22
- 23andMe presents poster for expansion chohorts for 23ME-00610
- 10/27/22
- 23andMe granted FDA 510(k) clearance for PGt report for SLCO1B1
- 09/19/22
- 23andMe appoints Daniel Chu as CPO
- 08/19/22
- 23andMe CFO Steven Schoch to step down
- 02/08/23
- Medtronic announces late-breaking clinical data from STROKE AF trial
- 01/30/23
- Medtronic recalls Hemodialysis Catheters for leaks, FDA says
- 01/27/23
- Orchestra BioMed begins trading on Nasdaq with cash runway into 2026
- 01/25/23
- Medtronic recommends rejection of below-market mini-tender by TRC Capital
- $18.42 /
-2.065 (-10.08%) - 02/08/23
- Mattel CEO: Our products are in demand and our business fundamentals are strong
- 02/08/23
- Mattel sees FY23 capex $175M-$200M vs. $187M in FY22
- 02/08/23
- Mattel says gross margins impacted by higher costs to manage inventory
- 02/08/23
- Mattel falls 10% to $18.50 after Q4 earnings miss, below-consensus guidance
- 02/06/23
- Southwest Dispatchers and Facilities Maintenance Technicians approve CBAs
- 02/01/23
- Southwest promotes Lauren Woods to chief information officer
- 01/26/23
- Southwest says it continues to experience year-over-year inflationary pressures
- 01/26/23
- Southwest plans to add 7,000 workers in 2023
- 02/09/23
- Kellogg sees FY23 tax rate 22%
- 02/09/23
- Kellogg working towards N.A. cereal spin-off, to retain plant-based business
- 02/09/23
- Kellogg CEO says entering 2023 in solid financial condition
- 01/30/23
- Colgate-Palmolive names Steve Cahillane to Board of Directors
- 12/05/22
- Hims & Hers names Scott Knoer as 1st Chief Pharmacy & Innovation Officer
- 11/15/22
- Amazon announces 'Amazon Clinic' virtual health service
- 11/08/22
- Hims & Hers rises 26.0%
- 11/08/22
- Hims & Hers rises 20.1%
- $63.41 /
-13.71 (-17.78%) - 02/09/23
- Globus Medical falls -17.3%
- 02/09/23
- Globus Medical falls -14.5%
- 02/09/23
- Globus Medical falls -14.9%
- 01/31/23
- Nevada reports December statewide gaming win up 14.3% to $1.31B
- 01/30/23
- Bragg Gaming launches new content with DraftKings in New Jersey
- 12/30/22
- DraftKings to launch online sportsbook in Ohio on New Year's Day
- 12/29/22
- Cathie Wood's ARK Investment bought 137K shares of DraftKings today
- $113.43 /
+1.655 (+1.48%) - 02/09/23
- Trian concludes proxy campaign with Disney, withdraws Peltz nomination
- 02/09/23
- Nelson Peltz says 'proxy fight is over' with Disney after last night's report
- 02/09/23
- Disney's Iger to CNBC: Board work on sucecssor 'already underway'
- 02/09/23
- Disney CEO Iger: 'My preference' is to stay for two years
- $10.25 /
+1.105 (+12.08%) - 02/09/23
- DHT Holdings rises 13.5%
- 01/09/23
- DHT Holdings:Q4 time charter equivalent fleet earnings ~ $56,900 per day
- 09/08/22
- DHT Holdings announces new dividend policy
- 08/29/22
- DHT Holdings announces sale of DHT Edelweiss
CSII Cardiovascular Systems - 02/08/23
- Cardiovascular Systems trading resumes
- 02/08/23
- Cardiovascular Systems trading halted, news pending
- 02/08/23
- Salesforce CEO teases AI efforts, says 'get ready to be wowed' by EinsteinGPT
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/22/23
- Fly Intel: Top five weekend stock stories
- 01/12/23
- Walmart enters partnership with Salesforce to provide solutions for retailers
- 02/07/23
- AstraZeneca's Forxiga approved in E.U. for treatment of chronic heart failure
- 02/02/23
- Amgen's Tezspire approved in U.S. for self-administration in severe asthma
- 01/26/23
- AstraZeneca continuing to work with FDA to collect data on Evusheld and variants
- 01/26/23
- FDA announces Evusheld not currently authorized for emergency use in U.S.
- 10/05/22
- Digital Turbine announces investment in Aptoide app store
- $16.31 /
+3.625 (+28.58%) - 02/08/23
- AppLovin jumps 28% to $16.18 after Q4 results and guidance
- 11/30/22
- AppLovin exec sells $17.6M in common stock
- 11/29/22
- AppLovin CMO Jansen sells 48,562 class A shares
- 11/09/22
- AppLovin says 'uniquely positioned to emerge from downturn'
- 02/06/23
- Cathie Wood's ARK Investment bought 313.7K shares of Accolade today
- $109.77 /
-0.465 (-0.42%) - 02/08/23
- Cardiovascular Systems jumps 43% after announcing it is being acquired by Abbott
- 02/08/23
- Abbott to acquire Cardiovascular Systems for $20 per share, or $890M
- 01/26/23
- Abbott: FDA approves Proclaim XR spinal cord stimulation system
- 01/25/23
- Abbott expects $2B in covid testing in FY23
- 02/09/23
- AbbVie says 'high level of confidence' in achieving FY23 guidance
- 02/09/23
- AbbVie expects inflation to weigh on aesthetics business in 2023
- 02/09/23
- AbbVie says breadth, depth of pipeline supports long term growth outlook
- 02/09/23
- AbbVie reports Q4 global Humira net revenues $5.58B, up 4.6% on reported basis
- 01/11/23
- AllianceBernstein reports preliminary AUM $646B as of December 31, 2022
- 12/12/22
- AllianceBernstein reports preliminary AUM $658B as of November 30
- 11/30/22
- Janus Henderson names Michelle Dunstan Chief Responsibility Officer
- 11/22/22
- AllianceBernstein, Societe Generale to form cash equities JV
- $153.00 /
+1.055 (+0.69%) - 02/02/23
- Apple pares decline during Q1 conference call, now down 1% at $149.35 afterhours
- 02/02/23
- Apple CFO says 'doing a lot of work on cost structure' to help gross margin
- 02/02/23
- Apple CFO says y/y performance of Q2 to be similar to Q1
- 02/02/23
- Apple CFO Maestri says customer satisfaction for iPhone 14 at 98%
- $153.00 /
+1.055 (+0.69%) - 02/07/23 Craig-Hallum
- Skyworks price target raised to $130 from $120 at Craig-Hallum
- 02/07/23 Credit Suisse
- Skyworks price target raised to $135 from $125 at Credit Suisse
- 02/07/23 KeyBanc
- Skyworks price target raised to $130 from $120 at KeyBanc
- 02/06/23 Credit Suisse
- Credit Suisse reiterates Outperform on Dell Technologies after 5% headcount cut
- 01/31/23 Bernstein
- Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
- 01/24/23 Mizuho
- Medtronic price target lowered to $95 from $100 at Mizuho
- 01/09/23 RBC Capital
- Medtronic downgraded to Sector Perform from Outperform at RBC Capital
- 11/30/22 Wells Fargo
- Medtronic price target lowered to $77 from $82 at Wells Fargo
- $113.43 /
+1.655 (+1.48%) - 02/09/23 Loop Capital
- Disney price target raised to $130 from $120 at Loop Capital
- 02/09/23 BofA
- Disney price target raised to $135 from $115 at BofA
- 02/09/23 KeyBanc
- Disney price target raised to $130 from $119 at KeyBanc
- 02/09/23 Credit Suisse
- Disney price target raised to $133 from $126 at Credit Suisse
- $109.77 /
-0.465 (-0.42%) - 02/09/23 Lake Street
- Cardiovascular Systems downgraded to Sell from Buy at Lake Street
- 02/07/23 Needham
- Surmodics price target lowered to $34 from $46 at Needham
- 01/27/23 Barclays
- Abbott price target raised to $125 from $122 at Barclays
- 01/26/23 Piper Sandler
- Abbott approval 'incremental headwind' to Nevro, says Piper Sandler
CSII Cardiovascular Systems - 12/21/22 Barclays
- Cardiovascular Systems initiated with an Equal Weight at Barclays
- 12/14/22 Lake Street
- Cardiovascular Systems initiated with a Buy at Lake Street
- 03/02/22 BofA
- Cardiovascular Systems reinstated with an Underperform at BofA
- 12/20/22 Atlantic Equities
- Coca-Cola, Pepsi remain preferred beverage names at Atlantic Equities
- 12/07/22 Argus
- PepsiCo price target raised to $206 from $195 at Argus
- 12/06/22 Deutsche Bank
- PepsiCo price target raised to $186 from $181 at Deutsche Bank
- 11/04/22 Redburn
- PepsiCo initiated with a Sell at Redburn
- 02/07/23 Barclays
- Post Holdings price target raised to $105 from $102 at Barclays
- 02/06/23 Truist
- Post Holdings price target raised to $85 from $70 at Truist
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 11/29/22 Piper Sandler
- Post Holdings price target raised to $115 from $107 at Piper Sandler
- 02/09/23 Bernstein
- Bernstein ponders takeover targets for J.M. Smucker after pet food sale
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight at Morgan Stanley on defensive positioning
- 12/20/22 Morgan Stanley
- J.M. Smucker upgraded to Equal Weight from Underweight at Morgan Stanley
- 12/15/22 Stifel
- J.M. Smucker price target raised to $155 from $148 at Stifel
- 02/09/23 Piper Sandler
- Piper downgrades NuVasive, Globus on merger agreement
- 02/09/23 Piper Sandler
- NuVasive downgraded to Neutral from Overweight at Piper Sandler
- 01/06/23 Needham
- NuVasive downgraded to Hold from Buy at Needham
- 11/10/22 TD Cowen
- NuVasive price target lowered to $50 from $65 at Cowen
- $63.41 /
-13.71 (-17.78%) - 02/09/23 Piper Sandler
- Globus Medical downgraded to Neutral from Overweight at Piper Sandler
- 01/04/23 Barclays
- Globus Medical price target raised to $82 from $70 at Barclays
- 10/18/22 Barclays
- Barclays starts medical devices with Positive view, Boston Scientific top pick
- 02/09/23 Roth MKM
- Roth MKM downgrades DraftKings to Sell with $15 price target
- 02/09/23 Roth MKM
- DraftKings downgraded to Sell from Neutral at Roth MKM
- 02/01/23 Piper Sandler
- DraftKings layoffs should be viewed positively, says Piper Sandler
- 01/23/23 Stifel
- DraftKings initiated with a Hold at Stifel
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy at Jefferies ahead of FY23 guidance
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy from Hold at Jefferies
- 01/10/23 Tigress Financial
- Hims & Hers price target raised to $12 from $11 at Tigress Financial
- 01/03/23 Piper Sandler
- Hims & Hers price target raised to $7 from $6 at Piper Sandler
- 02/09/23 Jefferies
- Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results
- 02/09/23 Jefferies
- Accolade downgraded to Hold from Buy at Jefferies
- 02/02/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/01/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/09/23 Canaccord
- Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook
- 02/09/23 Mizuho
- Rapid7 price target raised to $45 from $40 at Mizuho
- 02/09/23 Baird
- Rapid7 price target lowered to $56 from $58 at Baird
- 02/09/23 Raymond James
- Rapid7 price target raised to $55 from $50 at Raymond James
- 02/09/23 Morgan Stanley
- New York Times price target raised to $40 from $37 at Morgan Stanley
- 02/09/23 Barclays
- New York Times upgraded to Equal Weight from Underweight at Barclays
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 02/01/23 Deutsche Bank
- Salesforce evaluating value options, shares have 35% upside, says Deutsche
- 01/30/23 Morgan Stanley
- Salesforce price target raised to $236 from $228 at Morgan Stanley
- 01/27/23 BMO Capital
- SAP price target raised to $125 from $110 at BMO Capital
- 01/23/23 Deutsche Bank
- Salesforce price target lowered to $190 from $200 at Deutsche Bank
- 02/08/23 Redburn
- Southwest downgraded to Neutral from Buy at Redburn
- 01/27/23 Deutsche Bank
- Southwest price target lowered to $52 from $56 at Deutsche Bank
- 01/27/23 TD Cowen
- Southwest price target lowered to $50 from $55 at Cowen
- 01/12/23 Barclays
- Southwest price target lowered to $42 from $48 at Barclays
- 02/02/23 Argus
- Exxon Mobil price target raised to $133 from $128 at Argus
- 02/02/23 TD Cowen
- Exxon Mobil price target raised to $113 from $108 at Cowen
- 02/01/23 Truist
- Exxon Mobil price target raised to $110 from $101 at Truist
- 02/01/23 BofA
- Exxon Mobil price target raised to $140 from $136 at BofA
- 02/07/23 Evercore ISI
- AllianceBernstein added to 'Tactical Outperform' list at Evercore ISI
- 10/18/22 Credit Suisse
- AllianceBernstein initiated with a Neutral at Credit Suisse
- 09/07/22 BofA
- AllianceBernstein reinstated with a Neutral at BofA
- 09/07/22 BofA
- AllianceBernstein reinstated with a Neutral at BofA
- $16.31 /
+3.625 (+28.58%) - 02/09/23 Morgan Stanley
- AppLovin signs of stability 'count as a win,' says Morgan Stanley
- 02/08/23 Credit Suisse
- AppLovin price target lowered to $47 from $57 at Credit Suisse
- 02/06/23 KeyBanc
- AppLovin price target lowered to $20 from $25 at KeyBanc
- 01/27/23 DA Davidson
- Playtika cut to Neutral at DA Davidson on market share loss, Rovio offer
- $21.04 /
+3.185 (+17.84%) - 10/17/22 Morgan Stanley
- Sonos price target lowered to $17 from $20 at Morgan Stanley
- 08/11/22 Morgan Stanley
- Sonos price target lowered to $20 from $28 at Morgan Stanley
- 08/11/22 Stifel
- Sonos price target lowered to $20 from $24 at Stifel
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures
- $10.25 /
+1.105 (+12.08%) - 11/29/22 Jefferies
- DHT Holdings price target raised to $12 from $11 at Jefferies
- 07/20/22 Jefferies
- DHT Holdings initiated with a Buy at Jefferies
- 07/19/22 Stifel
- DHT Holdings price target raised to $8.50 from $7.50 at Stifel
- 04/27/22 Jefferies
- DHT Holdings reinstated with a Buy at Jefferies
- 11/28/22 Berenberg
- Berenberg starts 'well-positioned' 23andMe with a Buy
- 11/28/22 Berenberg
- 23andMe initiated with a Buy at Berenberg
- 09/22/22 TD Cowen
- 23andMe initiated with Outperform, $6 target at Cowen
- 09/22/22 TD Cowen
- 23andMe initiated with an Outperform at Cowen
- 02/09/23 Craig-Hallum
- Digital Turbine price target lowered to $25 from $30 at Craig-Hallum
- 02/09/23 Oppenheimer
- Oppenheimer downgrades Digital Turbine on 'unclear' long-term growth
- 02/09/23 Oppenheimer
- Digital Turbine downgraded to Perform from Outperform at Oppenheimer
- 02/01/23 B. Riley
- B. Riley downgrades Digital Turbine on app economy softness
- 12/07/22 H.C. Wainwright
- Veru price target lowered to $18 from $21 at H.C. Wainwright
- 11/10/22 H.C. Wainwright
- Veru price target lowered to $21 from $24 at H.C. Wainwright
- 09/20/22 Oppenheimer
- Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged'
- 09/08/22 Oppenheimer
- Oppenheimer remains bullish on Veru, optimism for EUA unchanged
- 01/16/23 BofA
- Purple Innovation reinstated with an Underperform at BofA
- 11/10/22 Craig-Hallum
- Purple Innovation upgraded to Buy from Hold at Craig-Hallum
- 09/20/22 Craig-Hallum
- Purple Board likely to reject Coliseum's deal, says Craig-Hallum
- 09/20/22 Wedbush
- Purple Innovation price target raised to $5 from $3.30 at Wedbush
- 01/23/23 Barclays
- Capri Holdings price target raised to $72 from $56 at Barclays
- 01/23/23 Barclays
- Tapestry downgraded to Equal Weight from Overweight at Barclays
- 12/20/22 Raymond James
- Tapestry initiated with an Outperform at Raymond James
- 12/19/22 Raymond James
- Tapestry initiated with an Outperform at Raymond James
- 02/08/23 Truist
- Model N price target raised to $52 from $45 at Truist
- 01/26/23 JPMorgan
- AbbVie recent weakness a buying opportunity, says JPMorgan
- 01/05/23 Truist
- AbbVie price target raised to $180 from $160 at Truist
- 11/17/22 Credit Suisse
- AbbVie initiated with an Outperform at Credit Suisse
- 01/30/23 Deutsche Bank
- Kellogg price target lowered to $72 from $74 at Deutsche Bank
- 12/20/22 Morgan Stanley
- Kellogg price target raised to $74 from $72 at Morgan Stanley
- 11/15/22 Exane BNP Paribas
- Kellogg initiated with an Underperform at Exane BNP Paribas
- 08/08/22 RBC Capital
- Kellogg price target raised to $70 from $66 at RBC Capital
- 01/26/23 Citi
- Novartis downgraded to Neutral from Buy at Citi
- 01/18/23 Berenberg
- AstraZeneca price target raised to 126 GBp from 118 GBp at Berenberg
- 01/12/23 Guggenheim
- Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks
- 01/12/23 Barclays
- CinCor Pharma downgraded to Equal Weight from Overweight at Barclays
- $18.42 /
-2.065 (-10.08%) - 02/09/23 DA Davidson
- Mattel price target lowered to $23 from $31 at DA Davidson
- 01/31/23 Goldman Sachs
- Mattel assumed with a Buy at Goldman Sachs
- 10/26/22 DA Davidson
- Mattel price target lowered to $31 from $45 at DA Davidson
- 10/13/22 Jefferies
- Mattel price target lowered to $22, transferred with a Hold at Jefferies
- 01/31/23
- Exxon Mobil reports Q4 adjusted EPS $3.40, consensus $3.29
- 01/30/23
- Notable companies reporting before tomorrow's open
- 10/28/22
- Exxon Mobil reports Q3 adjusted EPS $4.45, consensus $3.79
- 02/09/23
- Veru reports Q1 EPS (46c), consensus (38c)
- 12/05/22
- Veru reports Q4 EPS (51c), consensus (30c)
- 08/11/22
- Veru reports Q3 EPS (28c), consensus (18c)
- 02/09/23
- Tapestry raises FY23 EPS view to $3.70-$3.75 from $3.60-$3.70, consensus $3.65
- 02/09/23
- Tapestry reports Q2 EPS $1.36, consensus $1.27
- $21.04 /
+3.185 (+17.84%) - 02/08/23
- Sonos affirms FY23 revenue view of $1.7B-$1.8B, consensus $1.73B
- 02/08/23
- Sonos reports Q1 EPS 79c, consensus 40c
- 11/16/22
- Sonos sees FY23 revenue $1.7B-$1.8B, consensus $1.72B
- 11/16/22
- Sonos reports Q4 adjusted EPS (32c), consensus (41c)
- 12/14/22
- J.M. Smucker backs FY23 adjusted EPS view $8.35 -$8.75, consensus $8.60
- 11/21/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.35-$8.75 from $8.20-$8.60
- 11/21/22
- J.M. Smucker reports Q2 adjusted EPS $2.40, consensus $2.19
- 08/23/22
- J.M. Smucker raises FY23 adjusted EPS view to $8.20-$8.60 from $7.85-$8.25
- 02/08/23
- Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c
- 02/08/23
- Rapid7 sees Q1 EPS 7c-10c, consensus 7c
- 02/08/23
- Rapid7 reports Q4 EPS 35c, consensus 18c
- 11/02/22
- Rapid7 sees FY22 EPS 17c-20c, consensus 11c
- 01/30/23
- Purple Innovation sees FY22 net loss ($97.5M)-($83.7M)
- 11/09/22
- Purple Innovation backs FY22 revenue view $570M-$590M, consensus $578.66M
- 11/09/22
- Purple Innovation reports Q3 adjusted EPS 3c, consensus (5c)
- 08/09/22
- Purple Innovation lowers 2022 sales outlook to $570M-$590M from $650M-$690M
- 02/02/23
- Post Holdings reports Q1 EPS $1.52, consensus 68c
- 11/17/22
- Post Holdings reports Q4 adjusted EPS 85c, consensus 70c
- 02/09/23
- PepsiCo sees FY23 core EPS $7.20, consensus $7.28
- 02/09/23
- PepsiCo sees FY23 core EPS growth 8%, consensus $7.28
- 02/09/23
- PepsiCo reports Q4 core EPS $1.67, consensus $1.65
- 02/08/23
- Notable companies reporting before tomorrow's open
- 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 02/09/23
- NuVasive sees FY23 net sales growth 6%-8%, consensus $1.28B
- 02/09/23
- NuVasive sees FY22 net sales growth 5.5%, consensus $1.21B
- 11/09/22
- NuVasive lowers FY22 non-GAAP EPS to $2.00-$2.10 from $2.15-$2.45
- 11/09/22
- NuVasive reports Q3 non-GAAP EPS 54c, consensus 54c
- 02/08/23
- 23andMe sees FY23 revenue $290M-$300M, consensus $276.59M
- 02/08/23
- 23andMe reports Q3 EPS (20c), consensus (19c)
- 11/07/22
- 23andMe sees FY23 revenue $260M-$280M, consensus $277.86M
- 11/07/22
- 23andMe reports Q2 EPS (15c), consensus (17c)
- 11/22/22
- Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40
- 11/22/22
- Medtronic says guidance assumes 2H23 reported revenue $15.4B-$15.6B
- 11/22/22
- Medtronic cuts FY23 EPS view to $5.25-$5.30 from $5.53-$5.65, consensus $5.53
- 11/22/22
- Medtronic reports Q2 EPS $1.30, consensus $1.28
- $18.42 /
-2.065 (-10.08%) - 02/08/23
- Mattel sees FY23 adjusted EPS $1.10-$1.20, consensus $1.66
- 02/08/23
- Mattel reports Q4 adjusted EPS 18c, consensus 29c
- 10/25/22
- Mattel cuts FY22 EPS view to $1.32-$1.42 from $1.42-$1.48
- 01/26/23
- Southwest sees Q1 revenue up 20%-24%, consensus $5.88B
- 01/26/23
- Southwest reports Q4 adjusted EPS (38c), consensus (9c)
- 01/25/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Kellogg sees FY23 EPS down 4% to down 2% on currency neutral basis
- 02/09/23
- Kellogg reports Q4 adjusted currency-neutral EPS 97c, consensus 84c
- 11/07/22
- Hims & Hers raises FY22 revenue view $519M-$522M from $470M-$485M
- 11/07/22
- Hims & Hers sees Q4 revenue $159M-$162M, consensus $134.3M
- 11/07/22
- Hims & Hers reports Q3 EPS (9c), consensus (10c)
- $63.41 /
-13.71 (-17.78%) - 02/09/23
- Globus Medical sees FY23 net sales growth 7%-8%, consensus $1.12B
- 02/09/23
- Globus Medical sees FY22 net sales growth 6.8%, consensus $1.03B
- 11/08/22
- Globus Medical sees FY22 EPS $2.03-$2.10, consensus $2.10
- 11/08/22
- Globus Medical reports Q3 EPS 50c, consensus 52c
- 11/04/22
- DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B
- 11/04/22
- DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B
- 11/04/22
- DraftKings reports Q3 revenue $502M, consensus $437.23M
- 11/03/22
- Notable companies reporting before tomorrow's open
- $113.43 /
+1.655 (+1.48%) - 02/08/23
- Disney reports Q1 EPS ex-items 99c, consensus 78c
- 02/08/23
- Notable companies reporting after market close
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- $10.25 /
+1.105 (+12.08%) - 02/08/23
- DHT Holdings reports Q4 EPS 38c, consensus 30c
- 11/07/22
- DHT Holdings reports Q3 EPS 4c, consensus (1c)
- 08/10/22
- DHT Holdings reports Q2 EPS 6c, consensus (4c)
CSII Cardiovascular Systems - 02/08/23
- Cardiovascular Systems reports Q2 EPS (20c), consensus (15c)
- 11/03/22
- Cardiovascular Systems sees FY22 revenue $255M-$265M, consensus $258.48M
- 11/03/22
- Cardiovascular Systems reports Q1 EPS (27c), consensus (23c)
- 11/30/22
- Salesforce raises FY23 EPS view to $4.92-$4.94, consensus $4.73
- 11/30/22
- Salesforce sees Q4 EPS $1.35-$1.37, consensus $1.34
- 11/30/22
- Salesforce reports Q3 EPS $1.40, consensus $1.21
- 11/30/22
- Notable companies reporting after market close
- 02/09/23
- AstraZeneca sees FY23 core EPS up high single to low double-digit percentage
- 02/09/23
- AstraZeneca reports Q4 core EPS $1.38, consensus $1.35
- 11/10/22
- AstraZeneca raises FY22 core EPS view to high 20s to low 30s percentage
- 11/10/22
- AstraZeneca reports Q3 core EPS $1.67, YTD core EPS $5.28
- 02/08/23
- Digital Turbine sees FY23 adjusted EPS $1.15-$1.20, consensus $1.41
- 02/08/23
- Digital Turbine reports Q3 adjusted EPS 29c, consensus 37c
- 11/09/22
- Digital Turbine sees Q3 adjusted EPS 36c-39c, consensus 38c
- 11/09/22
- Digital Turbine reports Q2 non-GAAP EPS 34c, consensus 33c
- $16.31 /
+3.625 (+28.58%) - 02/08/23
- AppLovin sees Q1 revenue $685M-$705M, consensus $682.2M
- 02/08/23
- AppLovin reports Q4 adjusted EBITDA up 17% at $260M
- 11/09/22
- AppLovin cuts FY22 revenue view from $2.84B-$3.14B to $2.80B-$2.81B
- 01/09/23
- Accolade guides initial FY24 revenue around $410M, consensus $405.4M
- 01/09/23
- Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M
- 01/09/23
- Accolade sees Q4 revenue $97M-$101M, consensus $101.7M
- 01/09/23
- Accolade reports Q3 EPS (56c), consensus (62c)
- $109.77 /
-0.465 (-0.42%) - 01/25/23
- Abbott sees FY23 adjusted EPS $4.30-$4.50, consensus $4.40
- 01/25/23
- Abbott reports Q4 adjusted EPS $1.03, consensus 92c
- 01/24/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08
- 02/09/23
- AbbVie sees FY23 revenue about $52B, consensus $54.21B
- 02/09/23
- AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65
- 02/09/23
- AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56
- 02/08/23
- AllianceBernstein reports Q4 adjusted EPS 70c, consensus 57c
- 10/28/22
- AllianceBernstein reports Q3 adjusted EPS 64c, consensus 57c
- $153.00 /
+1.055 (+0.69%) - 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
|
|
On The Fly
| ShowHide Related Items >><< - 01/10/23
- RMI launches virtual power plant partnership with GM, Google, Ford
- 01/05/23
- SunPower, Maxeon Solar extend current supply relationship
- 11/10/22
- California issues revised proposal on rooftop solar subsidies
- 11/07/22
- Notable companies reporting before tomorrow's open
- 01/17/23
- Crowdstrike adds two executives to its leadership team
- 01/12/23
- SentinelOne selected by JCDC to strengthen U.S. cybersecurity
- 12/06/22
- SentinelOne reports Q3 ARR up 106% to $487.4M
- 11/30/22
- SentinelOne falls -10.9%
- 02/01/23
- Rapid7 trading resumes
- 02/01/23
- Rapid7 trading halted, volatility trading pause
- 09/22/22
- Rapid7 enters multi-year partnership with The Bruins
- 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
KPRX Kiora Pharmaceuticals - 02/09/23
- Kiora Pharmaceuticals received IND approval for Phase 2 study of KIO-101
- 01/03/23
- Kiora Pharmaceuticals completes enrollment in PCED study for KIO-201
- 10/18/22
- Kiora Pharmaceuticals Inc trading resumes
- 10/18/22
- Kiora Pharmaceuticals Inc trading halted, volatility trading pause
- 02/08/23
- Chase to hire over 500 small business bankers through 2024
- 01/20/23
- JPMorgan Asset Management receives approval for 100% ownership of China JV
- 01/13/23
- JPMorgan says continues to expect 17% ROTCE in 2023
- 01/13/23
- JPMorgan says targeting potential $12B in share buybacks in 2023
- 12/05/22
- Hims & Hers names Scott Knoer as 1st Chief Pharmacy & Innovation Officer
- 11/15/22
- Amazon announces 'Amazon Clinic' virtual health service
- 11/08/22
- Hims & Hers rises 26.0%
- 11/08/22
- Hims & Hers rises 20.1%
- 12/15/22
- Emcore announces sale, leaseback of Tinley Park facility
- 12/06/22
- Emcore introduces new TAC-450 Inertial Measurement Units
- 09/15/22
- Emcore to showcase product portfolio at ION GNSS+
- 08/22/22
- Direct Digital appoints Maria Vilchez as Chief Growth Officer
- 01/31/23
- Nevada reports December statewide gaming win up 14.3% to $1.31B
- 01/30/23
- Bragg Gaming launches new content with DraftKings in New Jersey
- 12/30/22
- DraftKings to launch online sportsbook in Ohio on New Year's Day
- 12/29/22
- Cathie Wood's ARK Investment bought 137K shares of DraftKings today
- 02/07/23
- Cerence enhances driving experience for Mercedes-Benz tour guide feature
- 01/09/23
- Cerence announces BYD to deploy its conversational AI in BYD EVs worldwide
- 01/04/23
- Cerence announces continued strategic partnership with what3words
- 12/14/22
- Cerence enters partnerships with iHeartMedia, Radioline
- 12/05/22
- Coupang director sells $7.47M in common stock
- 12/05/22
- Coupang falls -7.4%
- 11/09/22
- Coupang reports Q3 active customers up 7% y/y
- 02/08/23
- BofA to offer residential EV charger financing alongside auto loans
- 02/06/23
- Bank of America exec Koder sells 214,745 common shares
- 01/13/23
- Bank of America sees mid-single digit loan growth next year
- 01/13/23
- Bank of America sees Q1 NII around $14.4B
- 02/08/23
- Affirm sinks 18% to $13.02 after Q2 miss, outlook reduction
- 02/08/23
- Affirm cuts 2023 outlook amid macroeconomic headwinds
- 02/08/23
- Affirm sees $77M-$83M in annualized cost savings
- 02/08/23
- Affirm to reduce workforce by 19%, effective today
- 02/06/23
- Cathie Wood's ARK Investment bought 313.7K shares of Accolade today
- 02/09/23 Morgan Stanley
- New York Times price target raised to $40 from $37 at Morgan Stanley
- 02/09/23 Barclays
- New York Times upgraded to Equal Weight from Underweight at Barclays
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 02/09/23 Canaccord
- Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook
- 02/09/23 Mizuho
- Rapid7 price target raised to $45 from $40 at Mizuho
- 02/09/23 Baird
- Rapid7 price target lowered to $56 from $58 at Baird
- 02/09/23 Raymond James
- Rapid7 price target raised to $55 from $50 at Raymond James
- 02/09/23 Roth MKM
- Roth MKM downgrades DraftKings to Sell with $15 price target
- 02/09/23 Roth MKM
- DraftKings downgraded to Sell from Neutral at Roth MKM
- 02/01/23 Piper Sandler
- DraftKings layoffs should be viewed positively, says Piper Sandler
- 01/23/23 Stifel
- DraftKings initiated with a Hold at Stifel
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy at Jefferies ahead of FY23 guidance
- 02/09/23 Jefferies
- Hims & Hers upgraded to Buy from Hold at Jefferies
- 01/10/23 Tigress Financial
- Hims & Hers price target raised to $12 from $11 at Tigress Financial
- 01/03/23 Piper Sandler
- Hims & Hers price target raised to $7 from $6 at Piper Sandler
- 02/09/23 Jefferies
- Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results
- 02/09/23 Jefferies
- Accolade downgraded to Hold from Buy at Jefferies
- 02/02/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/01/23 Raymond James
- Accolade initiated with an Outperform at Raymond James
- 02/09/23 Northland
- Emcore upgraded to Outperform at Northland on potential cable optics sale
- 02/09/23 Lake Street
- Emcore upgraded to Buy at Lake Street with CATV business at bottom
- 02/09/23 Lake Street
- Emcore upgraded to Buy from Hold at Lake Street
- 02/09/23 Northland
- Emcore upgraded to Outperform from Market Perform at Northland
- 02/09/23 Craig-Hallum
- Craig-Hallum upgrades Cerence to Buy, ups price target to $40
- 02/09/23 Craig-Hallum
- Cerence upgraded to Buy from Hold at Craig-Hallum
- 02/09/23 Wells Fargo
- Cerence price target raised to $32 from $25 at Wells Fargo
- 02/09/23 Baird
- Cerence price target raised to $30 from $23 at Baird
KPRX Kiora Pharmaceuticals - 02/09/23 Maxim
- Kiora Pharmaceuticals upgraded to Buy at Maxim after IND approval for KIO-101
- 02/09/23 Maxim
- Kiora Pharmaceuticals upgraded to Buy from Hold at Maxim
- 02/07/23 Ladenburg
- Ladenburg reiterates Buy on Kiora following Phase 2 KIO-101 OPRA+ IND clearance
- 01/03/23 Ladenburg
- Kiora Pharmaceuticals completes enrollment in Phase 2 study, says Ladenburg
- 02/08/23 Keefe Bruyette
- Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform
- 02/08/23 Keefe Bruyette
- Bank of America downgraded to Underperform at Keefe Bruyette
- 01/31/23 Atlantic Equities
- Bank of America downgraded to Neutral from Overweight at Atlantic Equities
- 01/24/23 BofA
- Banks' potential new online wallet unlikely to threaten PayPal, says BofA
- 01/17/23 Citi
- JPMorgan price target raised to $165 from $150 at Citi
- 01/17/23 Piper Sandler
- JPMorgan price target raised to $157 from $150 at Piper Sandler
- 02/09/23 Deutsche Bank
- Affirm price target lowered to $12 from $18 at Deutsche Bank
- 02/09/23 DA Davidson
- Affirm price target lowered to $20 from $24 at DA Davidson
- 02/09/23 RBC Capital
- RBC Capital cuts Affirm to Sector Perform on higher funding costs, slower sales
- 02/09/23 Truist
- Affirm price target lowered to $17 from $21 at Truist
- 02/09/23 Barclays
- Coupang initiated with an Overweight at Barclays
- 12/01/22 New Street
- Coupang initiated with a Buy at New Street
- 11/29/22 Bernstein
- Coupang not gaining market share fast enough, says Bernstein
- 10/07/22 HSBC
- Coupang initiated with a Buy at HSBC
- 02/09/23 Canaccord
- Canaccord starts 'long-term secular winner' SentinelOne with Buy
- 02/09/23 Canaccord
- SentinelOne initiated with a Buy at Canaccord
- 01/24/23 JPMorgan
- SentinelOne initiated with an Overweight at JPMorgan
- 01/23/23 Guggenheim
- SentinelOne initiated with a Buy at Guggenheim
- 02/09/23 Janney Montgomery Scott
- Janney starts SunPower at Neutral with $16 fair value estimate
- 02/09/23 Janney Montgomery Scott
- SunPower initiated with a Neutral at Janney Montgomery Scott
- 01/25/23 Barclays
- SunPower downgraded to Underweight from Equal Weight at Barclays
- 01/17/23 Deutsche Bank
- SunPower price target raised to $21 from $16 at Deutsche Bank
- 02/09/23 EF Hutton
- Direct Digital initiated with a Buy at EF Hutton
- 07/12/22 Noble Capital
- Direct Digital initiated with an Outperform at Noble Capital
- 03/28/22 Roth MKM
- Direct Digital initiated with a Buy at Roth Capital
- 03/08/22 Benchmark
- Benchmark starts 'unique asset' in ad-tech Direct Digital at Buy
- 02/09/23 Raymond James
- Vertex initiated with an Outperform at Raymond James
- 02/08/23 Raymond James
- Vertex initiated with an Outperform at Raymond James
- 01/05/23 Jefferies
- Vertex downgraded to Hold from Buy at Jefferies
- 10/21/22 Citi
- Vertex price target raised to $16 from $15 at Citi
- 11/09/22
- Vertex sees Q4 revenue $124M-$127M, consensus $125.19M
- 11/09/22
- Vertex sees FY22 revenue $484.5M-$487.5M, consensus $482.11M
- 11/09/22
- Vertex reports Q3 non-GAAP EPS 8c, consensus 6c
- 11/08/22
- SunPower backs FY22 adjusted EBITDA view $90M-$110M
- 11/08/22
- SunPower reports Q3 adjusted cont ops EPS 13c, consensus 8c
- 12/06/22
- SentinelOne sees FY23 revenue $420M-$421M, consensus $416.3M
- 12/06/22
- SentinelOne sees Q4 revenue $125M, consensus $124.6M
- 12/06/22
- SentinelOne reports Q3 EPS (35c), consensus (22c)
- 12/06/22
- Notable companies reporting after market close
- 02/08/23
- Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c
- 02/08/23
- Rapid7 sees Q1 EPS 7c-10c, consensus 7c
- 02/08/23
- Rapid7 reports Q4 EPS 35c, consensus 18c
- 11/02/22
- Rapid7 sees FY22 EPS 17c-20c, consensus 11c
- 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 11/07/22
- Hims & Hers raises FY22 revenue view $519M-$522M from $470M-$485M
- 11/07/22
- Hims & Hers sees Q4 revenue $159M-$162M, consensus $134.3M
- 11/07/22
- Hims & Hers reports Q3 EPS (9c), consensus (10c)
- 02/08/23
- Emcore sees Q2 revenue $$27M$29M, two-estimates $27.5M
- 02/08/23
- Emcore reports Q1 EPS (22c), two-estimates (21c)
- 12/21/22
- Emcore sees Q1 revenue $25M-$27M, consensus $30.86M
- 12/21/22
- Emcore reports Q4 adjusted EPS (29c), consensus (17c)
- 11/10/22
- Direct Digital raises FY22 revenue view to $85M-$90M from $70M-$75M
- 11/10/22
- Direct Digital reports Q3 EPS 6c, consensus 5c
- 08/11/22
- Direct Digital raises FY22 revenue view to $70M-$75M, consensus $51.9M
- 08/11/22
- Direct Digital reports Q2 EPS 18c, consensus 6c
- 11/04/22
- DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B
- 11/04/22
- DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B
- 11/04/22
- DraftKings reports Q3 revenue $502M, consensus $437.23M
- 11/03/22
- Notable companies reporting before tomorrow's open
- 02/08/23
- Cerence sees FY23 revenue $275M-$290M, consensus $280.71M
- 02/08/23
- Cerence sees Q2 revenue $64M-$68M, consensus $68.25M
- 02/08/23
- Cerence reports Q1 EPS adjusted 36c, consensus 9c
- 11/29/22
- Cerence targets FY24 revenue of $385M, FY26 revenue of $515M
- 11/09/22
- Coupang reports Q3 EPS 5c, consensus (3c)
- 08/10/22
- Coupang raises FY22 adjusted EBITDA view
- 08/10/22
- Coupang reports Q2 EPS (4c), consensus (11c)
- 01/13/23
- Bank of America reports Q4 EPS 85c, consensus 77c
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/17/22
- Bank of America reports Q3 EPS 81c, consensus 77c
- 02/08/23
- Affirm sees FY23 revenue $1.475B-$1.55B, consensus $1.64B
- 02/08/23
- Affirm sees Q3 revenue $360M-$380M, consensus $417.96M
- 02/08/23
- Affirm reports Q2 EPS ($1.10), consensus (98c)
- 02/08/23
- Notable companies reporting after market close
- 01/09/23
- Accolade guides initial FY24 revenue around $410M, consensus $405.4M
- 01/09/23
- Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M
- 01/09/23
- Accolade sees Q4 revenue $97M-$101M, consensus $101.7M
- 01/09/23
- Accolade reports Q3 EPS (56c), consensus (62c)
|
|
Recommendations
|
Morgan Stanley analyst… Morgan Stanley analyst Thomas Yeh raised the firm's price target on New York Times to $40 from $37 and keeps an Equal Weight rating on the shares. Better-than-expected ad trends drove Q4 results and Q1 revenue guidance ahead of expectations, noted the firm, which sees balancing ARPU improvements with continued subscriber adoption as required to sustain double-digit digital subscription revenue growth as the Times' bundling strategy progresses. ShowHide Related Items >><< - $41.14 /
+4.485 (+12.24%) - 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- $41.14 /
+4.485 (+12.24%) - 02/09/23 Barclays
- New York Times upgraded to Equal Weight from Underweight at Barclays
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 08/04/22 Morgan Stanley
- New York Times price target lowered to $37 from $40 at Morgan Stanley
- $41.14 /
+4.485 (+12.24%) - 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- $41.14 /
+4.485 (+12.24%) - 12/16/22
- Twitter suspends journalists covering Musk, company, NBC News reports
- 12/09/22
- New York Times staffers went on strike Thursday, WSJ reports
- 10/20/22
- New York Times halts plans for children's app, WSJ reports
- 09/13/22
- Union members of New York Times, NBC News defy return-to-office, WSJ reports
- $41.14 /
+4.485 (+12.24%) - 02/08/23
- What You Missed On Wall Street On Wednesday
- 02/08/23
- What You Missed On Wall Street This Morning
- 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
|
|
Upgrade
|
Barclays analyst Kannan… Barclays analyst Kannan Venkateshwar upgraded New York Times to Equal Weight from Underweight with a price target of $36, up from $25, following the Q4 results. The company's growth model is "shifting quickly" towards profitability instead of growth, the analyst tells investors in a research note. The firm believes that if managed properly, New York Times could drive potential upside to long term margins. ShowHide Related Items >><< - $41.14 /
+4.485 (+12.24%) - 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- $41.14 /
+4.485 (+12.24%) - 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 08/04/22 Morgan Stanley
- New York Times price target lowered to $37 from $40 at Morgan Stanley
- 07/21/22 Guggenheim
- New York Times price target lowered to $34 from $41 at Guggenheim
- $41.14 /
+4.485 (+12.24%) - 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- $41.14 /
+4.485 (+12.24%) - 12/16/22
- Twitter suspends journalists covering Musk, company, NBC News reports
- 12/09/22
- New York Times staffers went on strike Thursday, WSJ reports
- 10/20/22
- New York Times halts plans for children's app, WSJ reports
- 09/13/22
- Union members of New York Times, NBC News defy return-to-office, WSJ reports
- $41.14 /
+4.485 (+12.24%) - 02/08/23
- What You Missed On Wall Street On Wednesday
- 02/08/23
- What You Missed On Wall Street This Morning
- 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 02/08/23
- Xponential Fitness falls -12.4%
- 01/19/23
- Xponential Fitness partners with Territory Foods
- 12/05/22
- Xponential Fitness signs master franchise agreement in Japan for Rumble, AKT
- 11/04/22
- Xponential Fitness signs master franchise agreement in Portugal for Club Pilates
WBD Warner Bros. Discovery - 01/31/23
- Tubi signs content deal with Warner Bros. Discovery
- 01/31/23
- Roku announces deal with Warner Bros. Discovery for new FAST channels
- 01/27/23
- HBO renews 'The Last of Us' for a second season
- 01/12/23
- Warner Bros. Discovery's HBO Max announces U.S. price increase
- 02/07/23
- VF Corp. expects Vans to be down high single digit percentage range in FY23
- 02/07/23
- VF Corp. sees $225M of annualized savings in fiscal 2024
- 02/07/23
- VF commencing strategic alternatives for Global Packs business
- 02/07/23
- VF Corp. cuts quarterly dividend to 30c from 51c per share
- 11/17/22
- General Motors, Vale sign long-term nickel supply agreement
- 08/15/22
- Vale fined BRL86.3M in Brazil over Brumadinho dam disclosures
- 01/25/23
- United Rentals initiates quarterly dividend of $1.48 per share
- 01/25/23
- United Rentals resumes stock buybacks, to repurchase $1.0B in 2023
- 11/14/22
- United Rentals to acquire Ahern Rentals for $2B
- 11/07/22
- United Rentals appoints Ted Grace as CFO
- 02/08/23
- Uber expects to generate $1B in ad revenue in 2023
- 02/08/23
- Uber sees West Coast trips approaching pre-Covid levels
- 02/08/23
- Uber looking to deliver GAAP operating profit 'at some point this year'
- 02/08/23
- Uber sees ordering, rides frequency continuing to rise
- 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 11/30/22
- TripAdvisor says Kanika Soni to leave position as Chief Commercial Officer
- 11/15/22
- TripAdvisor names John Boris as Chief Marketing Officer
- 11/08/22
- TripAdvisor: 'Premature' to provide 2023 outlook
- 11/08/22
- TripAdvisor: Travel remains 'robust'
- 01/19/23
- Ondas receives network controller order from Siemens Mobility
- 12/08/22
- Siemens announces order for grid control, smart metering infrastructure in Egypt
- 12/06/22
- Siemens, BWP, LiCAP partner for dry electrode manufacturing equipment
- 10/06/22
- Ecolab and Siemens partner to help to reduce greenhouse gas emissions
- 02/08/23
- CVS Health to acquire Oak Street Health for $39 per share
- 02/07/23
- Oak Street Health rises 30.0%
- 02/07/23
- Oak Street Health notes policy not to comment on unusual market activity
- $41.14 /
+4.485 (+12.24%) - 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- $76.56 /
+11.855 (+18.32%) - 02/08/23
- New Relic rises 19.5%
- 02/08/23
- New Relic rises 23.1%
- 02/08/23
- New Relic rises 20.4%
- 11/15/22
- New Relic director sells $11.8M in common stock
- $266.82 /
-0.755 (-0.28%) - 02/08/23
- Fortinet launches Cybercrime Atlas initiative
- 02/08/23
- CMA says Microsoft-Activision deal 'could harm UK gamers'
- 02/07/23
- Microsoft unveils new AI-powered Bing search engine and Edge browser
- 02/07/23
- KnowBe4 joins MISA, integrates with Microsoft security products
- 02/08/23
- Manchester United rises 13.6%
- 02/08/23
- Manchester United rises 13.4%
- 02/08/23
- Manchester United rises 13.4%
- 12/15/22
- Manchester United, TeamViewer reach agreement on future partnership
- 02/08/23
- Lumen falls -24.6%
- 02/08/23
- Lumen falls -18.6%
- 02/08/23
- Lumen falls -17.4%
- 02/07/23
- Lumen provides update on divestiture of EMEA business to Colt
- 02/07/23
- Hertz says Teslas made up 11% of vehicle fleet at end of 2022
- 02/02/23
- Netflix, GM partner to increase EV presence in Netflix-produced shows, films
- 01/31/23
- General Motors CEO: Couldn't be more excited about EV launches this year
- 01/31/23
- General Motors not contemplating big price increases this year
- 02/06/23
- Fortinet announces FortiSP5 ASIC technology
- 01/30/23
- Fortinet expands services, training offerings to further support SOC teams
- 01/12/23
- Fortinet announces participation in AT&T Pebble Beach Pro-Am
- $115.59 /
-2.295 (-1.95%) - 01/19/23
- Discover sees FY23 NIM modestly higher vs. FY22
- 01/17/23
- Cantaloupe appoints Novoseletsky as Chief Legal, Compliance Officer
- 11/16/22
- Discover up 4% after announcing plans to resume stock repurchases
- 10/24/22
- Discover reports Q3 net charge-off rate 1.71%
- 02/08/23
- CVS Health says Oak Street Health deal has long term growth, earnings power
- 02/08/23
- CVS Health says ability to generate cash 'remains strong'
- 02/08/23
- CVS Health says entering 2023 with 'great momentum'
- 02/08/23
- CVS Health sees FY23 CapEx $2.8B-$3B
- 01/24/23
- Barclays appoints new co-heads of Investment Banking
- 12/16/22
- FDIC identifies deficiencies in Credit Suisse, BNP Paribus 2021 plan submissions
- 12/02/22
- Credit Suisse rallies after Chairman says outflows 'basically stopped'
- 11/23/22
- Credit Suisse sees likely loss for Wealth Management in Q4
- $50.80 /
-15.475 (-23.35%) - 02/08/23
- Capri Holdings falls -27.0%
- 02/08/23
- Capri Holdings falls -23.4%
- 02/08/23
- Capri Holdings falls -21.0%
- 02/08/23
- Capri Holdings falls 19% to $54.00 after Q3 results, FY23 guidance miss ests
- $1,637.22 /
-83.24 (-4.84%) - 02/07/23
- Chipotle CEO: Feeling very good about where we are right now
- 02/07/23
- Chipotle sees Q1 comparable restaurant sales growth in high-single digits
- 02/07/23
- Chipotle reports Q4 operating margin 13.6%, up from 8.1% last year
- 01/26/23
- Chipotle launches new hiring campaign
- 02/01/23
- Blackstone says BREIT repurchase requests exceeded monthly limit in January
- 01/11/23
- COPT forms two data center JVs with Blackstone Real Estate
- 01/03/23
- UC Investments to invest $4B in Blackstone Real Estate Income Trust
- 01/03/23
- Targa to acquire Blackstone's 25% interest in Grand Prix for $1.05B
- 01/31/23
- Iqvia teams with Alibaba for cloud commercial & clinical solutions in China
- 01/16/23
- Top five weekend stock stories
- 01/09/23
- Jack Ma to relinquish control of Ant Group
- 12/29/22
- Alibaba names new CTO as CEO steps in interim cloud head
- $178.99 /
+0.225 (+0.13%) - 02/01/23
- Credit card stocks down after CFPB proposes changes to late fee rules
- 02/01/23
- CFPB proposes lowering excessive credit card late fee cap to $8
- 02/01/23
- CFPB proposes rule to rein in excessive credit card late fees
- 01/27/23
- American Express rises 10.4%
- 02/03/23
- Activision Blizzard to pay $35M in settlement with SEC over whistleblower rule
- 01/24/23
- Microsoft sees Q3 productivity revenue $16.9B-$17.2B
- 01/19/23
- Sony announces additional games coming to PlayStation VR2
- 02/08/23
- Argo Group trading resumes
- 02/08/23
- Brookfield Reinsurance to acquire Argo Group in $1.1B transaction
- 02/08/23
- Brookfield Reinsurance to acquire Argo Group in $1.1B transaction
- 02/08/23
- Argo Group trading halted, news pending
- 09/12/22 Compass Point
- Argo Group upgraded to Buy at Compass Point after strategic transactions
- 09/12/22 Compass Point
- Argo Group upgraded to Buy from Neutral at Compass Point
- 08/10/22 Raymond James
- Argo Group downgraded to Market Perform from Outperform at Raymond James
- 08/09/22 Compass Point
- Argo Group downgraded to Neutral from Buy at Compass Point
- $266.82 /
-0.755 (-0.28%) - 02/09/23 Morgan Stanley
- Alphabet has AI tech, scale to maintain, grow search base, says Morgan Stanley
- 02/08/23 Morgan Stanley
- Activision Blizzard risk/reward 'highly compelling,' says Morgan Stanley
- 02/08/23 Atlantic Equities
- Microsoft's new Bing brings new competition, says Atlantic Equities
- 02/08/23 Morgan Stanley
- Microsoft 'coming out swinging' in ramping AI/ML tech cycle, says Morgan Stanley
- 01/27/23 Wedbush
- Activision Blizzard assumed with an Outperform at Wedbush
- 12/22/22 Needham
- Netflix 2023 estimates cut at Needham
- 12/06/22 Edward Jones
- Activision Blizzard upgraded to Buy from Hold at Edward Jones
- 02/09/23 Raymond James
- CVS Health price target lowered to $110 from $115 at Raymond James
- 02/09/23 Jefferies
- CVS Health price target raised to $143 from $130 at Jefferies
- 02/09/23 Jefferies
- Oak Street Health downgraded to Hold from Buy at Jefferies
- 02/09/23 Barclays
- CVS Health price target lowered to $110 from $118 at Barclays
- 02/09/23 William Blair
- Oak Street Health downgraded to Market Perform from Outperform at William Blair
- 02/08/23 Canaccord
- Oak Street Health downgraded to Hold from Buy at Canaccord
BNRE Brookfield Reinsurance - 02/09/23 JPMorgan
- Uber remains a top pick for 2023 after results at JPMorgan
- 02/09/23 Wells Fargo
- Uber price target raised to $53 from $46 at Wells Fargo
- 02/09/23 Susquehanna
- Uber price target raised to $40 from $32 at Susquehanna
- 02/09/23 Mizuho
- Uber price target raised to $50 from $46 at Mizuho
- $1,637.22 /
-83.24 (-4.84%) - 02/08/23 RBC Capital
- Chipotle price target lowered to $1,850 from $1,900 at RBC Capital
- 02/08/23 Truist
- Chipotle price target lowered to $1,800 from $1,825 at Truist
- 02/08/23 TD Cowen
- Chipotle price target raised to $2050 from $1950 at Cowen
- 02/08/23 Credit Suisse
- Chipotle price target raised to $2,050 from $1,950 at Credit Suisse
- $178.99 /
+0.225 (+0.13%) - 02/08/23 Morgan Stanley
- Discover downgraded to Equal Weight from Overweight at Morgan Stanley
- 02/08/23 Morgan Stanley
- American Express upgraded to Overweight from Equal Weight at Morgan Stanley
- 02/01/23 Citi
- Citi sees weakness in Synchrony after CFPB proposal as buying opportunity
- 02/01/23 BTIG
- CFPB credit card late fee proposal 'more onerous than expected,' says BTIG
- $115.59 /
-2.295 (-1.95%) - 01/24/23 Citi
- Discover price target raised to $118 from $113 at Citi
- 01/20/23 BMO Capital
- Discover price target lowered to $111 from $119 at BMO Capital
- 02/08/23 BofA
- TripAdvisor upgraded to Buy from Underperform at BofA
- 12/07/22 Wolfe Research
- TripAdvisor downgraded to Underperform from Peer Perform at Wolfe Research
- 11/25/22 DA Davidson
- TripAdvisor price target lowered to $30 from $33 at DA Davidson
- 11/09/22 Wells Fargo
- TripAdvisor price target lowered to $22 from $30 at Wells Fargo
- 02/08/23 Credit Suisse
- United Rentals initiated with an Outperform at Credit Suisse
- 01/31/23 Argus
- United Rentals price target raised to $475 from $360 at Argus
- 01/27/23 Deutsche Bank
- United Rentals price target raised to $399 from $341 at Deutsche Bank
- 01/27/23 Stifel
- United Rentals price target raised to $505 from $450 at Stifel
- 02/09/23 Loop Capital
- Fortinet price target raised to $80 from $66 at Loop Capital
- 02/09/23 Barclays
- Fortinet price target raised to $68 from $56 at Barclays
- 02/08/23 Deutsche Bank
- Fortinet price target raised to $63 from $53 at Deutsche Bank
- 02/08/23 RBC Capital
- Fortinet price target raised to $68 from $57 at RBC Capital
- 01/11/23 Barclays
- Alibaba price target raised to $141 from $114 at Barclays
- 01/10/23 Citi
- Alibaba price target raised to $160 from $144 at Citi
- 01/09/23 Morgan Stanley
- Alibaba price target raised to $150 from $100 at Morgan Stanley
- 01/08/23 Goldman Sachs
- Alibaba upgraded to Conviction Buy from Buy at Goldman Sachs
WBD Warner Bros. Discovery - 01/31/23 Macquarie
- Warner Bros. Discovery price target raised to $20 from $16 at Macquarie
- 01/30/23 Morgan Stanley
- Warner Bros. Discovery price target raised to $17 from $14 at Morgan Stanley
- 01/24/23 Atlantic Equities
- Atlantic sees 80% upside in Warner Bros. Discovery after analyzing merger
- 01/11/23 Guggenheim
- Guggenheim upgrades Warner Bros. Discovery to Buy, sees 31% potential upside
- 02/02/23 Citi
- Citi ups GM target, reiterates as top pick post results
- 02/01/23 Deutsche Bank
- General Motors price target raised to $36 from $33 at Deutsche Bank
- 02/01/23 Morgan Stanley
- General Motors price target raised to $35 from $32 at Morgan Stanley
- 02/01/23 BofA
- General Motors price target lowered to $70 from $80 at BofA
- 02/09/23 JPMorgan
- Vale downgraded to Neutral from Overweight at JPMorgan
- 02/06/23 RBC Capital
- RBC downgrades Vale, says shares 'moved past fair value'
- 02/06/23 RBC Capital
- Vale downgraded to Sector Perform from Outperform at RBC Capital
- 12/09/22 Morgan Stanley
- Vale upgraded to Overweight from Equal Weight at Morgan Stanley
- 01/27/23 Morgan Stanley
- Credit Suisse resumed with an Equal Weight at Morgan Stanley
- 01/13/23 Barclays
- Credit Suisse price target lowered to CHF 2.90 from CHF 4 at Barclays
- 01/13/23 Deutsche Bank
- Credit Suisse reinstated with a Hold at Deutsche Bank
- 12/20/22 Exane BNP Paribas
- Credit Suisse resumed with an Underperform at Exane BNP Paribas
- 01/27/23 BMO Capital
- Blackstone price target raised to $92 from $85 at BMO Capital
- 01/27/23 Barclays
- Blackstone price target raised to $100 from $86 at Barclays
- 01/24/23 JPMorgan
- TPG downgraded to Neutral from Overweight at JPMorgan
- 01/24/23 JPMorgan
- Blackstone upgraded to Overweight from Neutral at JPMorgan
- $76.56 /
+11.855 (+18.32%) - 02/09/23 Canaccord
- New Relic price target raised to $88 from $74 at Canaccord
- 02/08/23 Truist
- New Relic price target raised to $65 from $55 at Truist
- 02/08/23 RBC Capital
- New Relic price target raised to $75 from $55 at RBC Capital
- 02/08/23 Credit Suisse
- New Relic price target raised to $90 from $78 at Credit Suisse
- 12/09/22 Deutsche Bank
- Manchester United downgraded to Hold from Buy at Deutsche Bank
- 11/23/22 Jefferies
- Jefferies expects 'competitive process' for Manchester United
- 06/02/22 Deutsche Bank
- Manchester United undervalued after selloff, says Deutsche Bank
- 03/21/22 Deutsche Bank
- Manchester United upgraded on 'value disconnect' at Deutsche Bank
- $41.14 /
+4.485 (+12.24%) - 02/09/23 Morgan Stanley
- New York Times price target raised to $40 from $37 at Morgan Stanley
- 02/09/23 Barclays
- New York Times upgraded to Equal Weight from Underweight at Barclays
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 02/08/23 Citi
- Lumen downgraded to Sell from Neutral at Citi
- 12/06/22 Goldman Sachs
- Lumen reinstated with a Neutral at Goldman Sachs
- 11/14/22 Wells Fargo
- Dycom price target lowered to $120 from $130 at Wells Fargo
- 11/03/22 UBS
- Lumen price target lowered to $7 from $11 at UBS
- 01/13/23 B. Riley
- Xponential Fitness price target raised to $32 from $30 at B. Riley
- 01/10/23 Baird
- Xponential Fitness price target raised to $32 from $30 at Baird
- 12/06/22 Citi
- Xponential Fitness initiated with a Buy at Citi
- 11/18/22 Baird
- Xponential Fitness price target raised to $30 from $26 at Baird
- 02/09/23 Citi
- Under Armour price target lowered to $12 from $13 at Citi
- 02/06/23 Deutsche Bank
- Under Armour price target raised to $14 from $11 at Deutsche Bank
- 01/23/23 JPMorgan
- Under Armour price target raised to $13 from $11 at JPMorgan
- 12/22/22 William Blair
- Linnartz an 'interesting choice' to head Under Armour, says William Blair
- 01/17/23 Exane BNP Paribas
- Under Armour upgraded to Outperform from Neutral at Exane BNP Paribas
- 02/09/23 Baird
- VF Corp. price target lowered to $30 from $34 at Baird
- 02/09/23 Barclays
- VF Corp. price target raised to $31 from $28 at Barclays
- 02/08/23 Deutsche Bank
- VF Corp. price target lowered to $33 from $35 at Deutsche Bank
- 02/06/23 BTIG
- VF Corp. assumed with a Neutral at BTIG
- $50.80 /
-15.475 (-23.35%) - 02/09/23 BMO Capital
- Capri Holdings price target lowered to $70 from $74 at BMO Capital
- 02/09/23 Morgan Stanley
- Capri Holdings assumed with an Overweight at Morgan Stanley
- 02/09/23 UBS
- Capri Holdings price target lowered to $68 from $75 at UBS
- 02/09/23 Baird
- Capri Holdings price target lowered to $68 from $70 at Baird
- 02/03/23 Deutsche Bank
- Siemens price target raised to EUR 165 from EUR 155 at Deutsche Bank
- 01/27/23 Berenberg
- Siemens downgraded to Hold from Buy at Berenberg
- 01/04/23 Bernstein
- Siemens upgraded to Market Perform from Underperform at Bernstein
- 11/18/22 Barclays
- Siemens price target raised to EUR 94 from EUR 90 at Barclays
- 01/09/23
- Xponential Fitness expects to meet or exceed high end of FY22 outlook
- 11/10/22
- Xponential Fitness raises FY22 revenue view to $235M-$240M from $211M-$221M
- 11/10/22
- Xponential Fitness reports Q3 adjusted EPS 10c, consensus 14c
- 08/11/22
- Xponential Fitness raises FY22 revenue view to $211M-$221M from $201M-$211M
WBD Warner Bros. Discovery - 11/03/22
- Warner Bros. Discovery reports Q3 EPS (95c), consensus (21c)
- 11/03/22
- Warner Bros. Discovery reports Q3 revenue $9.82B, consensus $10.36B
- 11/03/22
- Notable companies reporting after market close
- 02/07/23
- VF Corp. sees FY24 operating earnings up double-digits
- 02/07/23
- VF Corp. sees FY23 adjusted EPS $2.05-$2.15 vs. prior $2.00-$2.20
- 02/07/23
- VF Corp. reports Q3 adjusted EPS $1.12, consensus 98c
- 01/25/23
- United Rentals sees FY23 revenue $13.7B-$14.2B, consensus $13.46B
- 01/25/23
- United Rentals reports Q4 EPS $9.15, consensus $10.37
- 10/26/22
- United Rentals raises 2022 revenue outlook to $11.5B-$11.7B from $11.4B-$11.7B
- 10/26/22
- United Rentals reports Q3 EPS $9.27, consensus $9.06
- 02/08/23
- Uber reports Q4 EPS 29c, consensus (18c)
- 02/07/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- Uber reports Q3 EPS (61c), consensus (22c)
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 11/07/22
- TripAdvisor sees Q4 revenue of low-single digit increases from 2019 levels
- 11/07/22
- TripAdvisor reports Q3 adjusted EPS 28c, consensus 38c
- 02/08/23
- Siemens raises 2023 outlook after 'strong start' to year
- 01/09/23
- Oak Street Health sees FY23 revenue $3.0B-$3.15B, consensus $3.05B
- 01/09/23
- Oak Street Health raises FY22 revenue view to at or above $2.155B
- 11/07/22
- Oak Street Health reports Q3 EPS (56c), consensus (61c)
- $41.14 /
+4.485 (+12.24%) - 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- $76.56 /
+11.855 (+18.32%) - 02/07/23
- New Relic sees Q4 adjusted EPS 20c-23c, consensus 15c
- 02/07/23
- New Relic sees FY23 adjusted EPS 40c-43c, consensus 19c
- 02/07/23
- New Relic reports Q3 adjusted EPS 32c, consensus 15c
- 11/08/22
- New Relic sees Q3 adjusted EPS 14c-17c, consensus 14c
- $266.82 /
-0.755 (-0.28%) - 01/24/23
- Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29
- 01/24/23
- Notable companies reporting after market close
- 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
- 12/08/22
- Manchester United reports Q2 adjusted EBITDA GBP 23.6M vs. GBP 11.2M y/y
- 09/22/22
- Manchester United sees FY23 revenue GBP 580M-GBP 600M
- 09/22/22
- Manchester United reports Q4 adjusted EPS (GBP 12.38) vs. (GBP 20.67) last year
- 02/07/23
- Lumen sees FY23 adjusted EBITDA $4.6B-$4.8B
- 02/07/23
- Lumen reports Q4 adjusted EPS 43c, consensus 19c
- 11/02/22
- Lumen reports Q3 adjusted EPS 14c, consensus 37c
- 01/31/23
- General Motors sees FY23 adjusted EPS $6.00-$7.00, consensus $5.81
- 01/31/23
- General Motors reports Q4 adjusted EPS $2.12, consensus $1.69
- 01/30/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Fortinet sees FY23 EPS $1.39-$1.41, consensus $1.39
- 02/07/23
- Fortinet sees Q1 EPS 27c-29c, consensus 27c
- 02/07/23
- Fortinet reports Q4 EPS 44c, consensus 39c
- $115.59 /
-2.295 (-1.95%) - 01/18/23
- Discover reports Q4 EPS $3.77, consensus $3.66
- 01/18/23
- Notable companies reporting after market close
- 10/24/22
- Discover Financial reports Q3 EPS $3.54, consensus $3.72
- 10/24/22
- Notable companies reporting after market close
- 02/08/23
- CVS Health sees FY23 revenue $332.7B-$338.5B, consensus $325.11B
- 02/08/23
- CVS Health reports Q4 adjusted EPS $1.99, consensus $1.92
- 02/08/23
- CVS Health sees FY24 adjusted EPS $9.00, FY25 adjusted EPS $10.00
- 02/08/23
- CVS Health backs FY23 adjusted EPS view $8.70-$8.90, consensus $8.86
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- $50.80 /
-15.475 (-23.35%) - 02/08/23
- Capri Holdings sees Q4 EPS 90c-95c, consensus $1.39
- 02/08/23
- Capri Holdings sees FY23 adjusted EPS $6.10, consensus $6.87
- 02/08/23
- Capri Holdings reports Q3 adjusted EPS $1.84, consensus $2.22
- $1,637.22 /
-83.24 (-4.84%) - 02/07/23
- Chipotle reports Q4 adjusted EPS $8.29, consensus $8.90
- 02/07/23
- Notable companies reporting after market close
- 10/25/22
- Chipotle reports Q3 adjusted EPS $9.51, consensus $9.21
- 10/25/22
- Notable companies reporting after market close
- 01/27/23
- Blackstone reports Q4 distributable EPS $1.07 vs. $1.71 y/y
- 01/25/23
- Notable companies reporting before tomorrow's open
- 01/25/23
- UC Investments to invest additional $500M in BREIT common shares
- 11/17/22
- Alibaba reports Q2 adjusted EPS $1.82, consensus $1.64
- 11/16/22
- Notable companies reporting before tomorrow's open
- $178.99 /
+0.225 (+0.13%) - 01/27/23
- American Express reports Q4 EPS $2.07, consensus $2.22
- 01/26/23
- Notable companies reporting before tomorrow's open
- 10/21/22
- American Express sees FY22 EPS above $9.25-$9.65, consensus $9.91
- 02/06/23
- Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51
- 02/06/23
- Notable companies reporting after market close
- 11/07/22
- Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c
- 11/07/22
- Notable companies reporting after market close
- 11/07/22
- Argo Group reports Q3 operating EPS 44c, consensus ($2.20)
- 08/08/22
- Argo Group reports Q2 operating EPS 89c vs $1.60 last year
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - $24.38 /
-3.305 (-11.94%) - 02/08/23
- Xponential Fitness falls -12.4%
- 01/19/23
- Xponential Fitness partners with Territory Foods
- 12/05/22
- Xponential Fitness signs master franchise agreement in Japan for Rumble, AKT
- 11/04/22
- Xponential Fitness signs master franchise agreement in Portugal for Club Pilates
WBD Warner Bros. Discovery - 01/31/23
- Tubi signs content deal with Warner Bros. Discovery
- 01/31/23
- Roku announces deal with Warner Bros. Discovery for new FAST channels
- 01/27/23
- HBO renews 'The Last of Us' for a second season
- 01/12/23
- Warner Bros. Discovery's HBO Max announces U.S. price increase
- 02/07/23
- VF Corp. expects Vans to be down high single digit percentage range in FY23
- 02/07/23
- VF Corp. sees $225M of annualized savings in fiscal 2024
- 02/07/23
- VF commencing strategic alternatives for Global Packs business
- 02/07/23
- VF Corp. cuts quarterly dividend to 30c from 51c per share
- 11/17/22
- General Motors, Vale sign long-term nickel supply agreement
- 08/15/22
- Vale fined BRL86.3M in Brazil over Brumadinho dam disclosures
- 01/25/23
- United Rentals initiates quarterly dividend of $1.48 per share
- 01/25/23
- United Rentals resumes stock buybacks, to repurchase $1.0B in 2023
- 11/14/22
- United Rentals to acquire Ahern Rentals for $2B
- 11/07/22
- United Rentals appoints Ted Grace as CFO
- 02/08/23
- Uber expects to generate $1B in ad revenue in 2023
- 02/08/23
- Uber sees West Coast trips approaching pre-Covid levels
- 02/08/23
- Uber looking to deliver GAAP operating profit 'at some point this year'
- 02/08/23
- Uber sees ordering, rides frequency continuing to rise
- 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 11/30/22
- TripAdvisor says Kanika Soni to leave position as Chief Commercial Officer
- 11/15/22
- TripAdvisor names John Boris as Chief Marketing Officer
- 11/08/22
- TripAdvisor: 'Premature' to provide 2023 outlook
- 11/08/22
- TripAdvisor: Travel remains 'robust'
- 02/08/23
- CVS Health to acquire Oak Street Health for $39 per share
- 02/07/23
- Oak Street Health rises 30.0%
- 02/07/23
- Oak Street Health notes policy not to comment on unusual market activity
- $41.43 /
+4.775 (+13.03%) - 02/08/23
- New York Times sees Q1 subscription revenue up 6%-9%
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- $77.16 /
+12.46 (+19.26%) - 02/08/23
- New Relic rises 19.5%
- 02/08/23
- New Relic rises 23.1%
- 02/08/23
- New Relic rises 20.4%
- 11/15/22
- New Relic director sells $11.8M in common stock
- $268.58 /
+1.005 (+0.38%) - 02/08/23
- Fortinet launches Cybercrime Atlas initiative
- 02/08/23
- CMA says Microsoft-Activision deal 'could harm UK gamers'
- 02/07/23
- Microsoft unveils new AI-powered Bing search engine and Edge browser
- 02/07/23
- KnowBe4 joins MISA, integrates with Microsoft security products
- $24.01 /
+2.945 (+13.98%) - 02/08/23
- Manchester United rises 13.6%
- 02/08/23
- Manchester United rises 13.4%
- 02/08/23
- Manchester United rises 13.4%
- 12/15/22
- Manchester United, TeamViewer reach agreement on future partnership
- 02/08/23
- Lumen falls -24.6%
- 02/08/23
- Lumen falls -18.6%
- 02/08/23
- Lumen falls -17.4%
- 02/07/23
- Lumen provides update on divestiture of EMEA business to Colt
- $15.90 /
+2.325 (+17.13%) - 02/08/23
- Kyndryl Holdings rises 16.5%
- 11/14/22
- Greenlight takes new stake in Intel, exits position in Atlas Air
- 10/06/22
- Kyndryl Holdings, Microsoft announce plans to expand partnership
- 09/29/22
- Kyndryl, Citrix enter workplace collaboration and employee productivity alliance
- 02/02/23
- Alphabet says started bringing revenue sharing to YouTube Shorts
- 02/07/23
- Toast announces the Order with Google integration, unlocking new order channel
- 02/06/23
- Google releases conversational AI service Bard for testing
- 02/06/23
- Texas Governor Abbott announces statewide plan banning use of TikTok
- 02/03/23
- Google, Anthropic partner to co-develop AI computing systems
- 02/07/23
- Hertz says Teslas made up 11% of vehicle fleet at end of 2022
- 02/02/23
- Netflix, GM partner to increase EV presence in Netflix-produced shows, films
- 01/31/23
- General Motors CEO: Couldn't be more excited about EV launches this year
- 01/31/23
- General Motors not contemplating big price increases this year
- 02/06/23
- Fortinet announces FortiSP5 ASIC technology
- 01/30/23
- Fortinet expands services, training offerings to further support SOC teams
- 01/12/23
- Fortinet announces participation in AT&T Pebble Beach Pro-Am
- 01/23/23
- Emerson Electric issues statement regarding National Instruments proposal
- 01/17/23
- National Instruments reiterates commitment to strategic review process
- 01/17/23
- National Instruments confirms receipt of acquisition proposal from Emerson
- 01/17/23
- Emerson Electric 'disappointed' National Instruments chose to announce review
- 01/19/23
- Discover sees FY23 NIM modestly higher vs. FY22
- 01/17/23
- Cantaloupe appoints Novoseletsky as Chief Legal, Compliance Officer
- 11/16/22
- Discover up 4% after announcing plans to resume stock repurchases
- 10/24/22
- Discover reports Q3 net charge-off rate 1.71%
- 02/08/23
- CVS Health says Oak Street Health deal has long term growth, earnings power
- 02/08/23
- CVS Health says ability to generate cash 'remains strong'
- 02/08/23
- CVS Health says entering 2023 with 'great momentum'
- 02/08/23
- CVS Health sees FY23 CapEx $2.8B-$3B
- 01/24/23
- Barclays appoints new co-heads of Investment Banking
- 12/16/22
- FDIC identifies deficiencies in Credit Suisse, BNP Paribus 2021 plan submissions
- 12/02/22
- Credit Suisse rallies after Chairman says outflows 'basically stopped'
- 11/23/22
- Credit Suisse sees likely loss for Wealth Management in Q4
- $48.59 /
-17.68 (-26.68%) - 02/08/23
- Capri Holdings falls -27.0%
- 02/08/23
- Capri Holdings falls -23.4%
- 02/08/23
- Capri Holdings falls -21.0%
- 02/08/23
- Capri Holdings falls 19% to $54.00 after Q3 results, FY23 guidance miss ests
- $1,627.11 /
-93.35 (-5.43%) - 02/07/23
- Chipotle CEO: Feeling very good about where we are right now
- 02/07/23
- Chipotle sees Q1 comparable restaurant sales growth in high-single digits
- 02/07/23
- Chipotle reports Q4 operating margin 13.6%, up from 8.1% last year
- 01/26/23
- Chipotle launches new hiring campaign
BNRE Brookfield Reinsurance - 02/08/23
- Brookfield Reinsurance to acquire Argo Group in $1.1B transaction
- 02/08/23
- Brookfield Reinsurance to acquire Argo Group in $1.1B transaction
- 01/31/23
- Iqvia teams with Alibaba for cloud commercial & clinical solutions in China
- 01/16/23
- Top five weekend stock stories
- 01/09/23
- Jack Ma to relinquish control of Ant Group
- 12/29/22
- Alibaba names new CTO as CEO steps in interim cloud head
- 02/01/23
- Credit card stocks down after CFPB proposes changes to late fee rules
- 02/01/23
- CFPB proposes lowering excessive credit card late fee cap to $8
- 02/01/23
- CFPB proposes rule to rein in excessive credit card late fees
- 01/27/23
- American Express rises 10.4%
- 02/03/23
- Activision Blizzard to pay $35M in settlement with SEC over whistleblower rule
- 01/24/23
- Microsoft sees Q3 productivity revenue $16.9B-$17.2B
- 01/19/23
- Sony announces additional games coming to PlayStation VR2
- 02/08/23
- Argo Group trading resumes
- 02/08/23
- Argo Group trading halted, news pending
- $268.58 /
+1.005 (+0.38%) - 02/08/23 Atlantic Equities
- Microsoft's new Bing brings new competition, says Atlantic Equities
- 02/08/23 Morgan Stanley
- Microsoft 'coming out swinging' in ramping AI/ML tech cycle, says Morgan Stanley
- 02/08/23 DA Davidson
- Microsoft price target raised to $325 from $280 at DA Davidson
- 02/08/23 Wells Fargo
- Wells says OpenAI investments place Microsoft 'front & center' of AI hype cycle
- 01/27/23 Wedbush
- Activision Blizzard assumed with an Outperform at Wedbush
- 12/22/22 Needham
- Netflix 2023 estimates cut at Needham
- 12/06/22 Edward Jones
- Activision Blizzard upgraded to Buy from Hold at Edward Jones
- 12/01/22 Wedbush
- Activision Blizzard added to Best Ideas List at Wedbush
- 02/08/23 Piper Sandler
- Oak Street Health downgraded to Neutral from Overweight at Piper Sandler
- 02/08/23 Stifel
- Oak Street Health downgraded to Hold from Buy at Stifel
- 02/07/23 Stifel
- Oak Street Health price target raised to $39 from $35 at Stifel
- 02/07/23 Piper Sandler
- Oak Street 'particularly attractive' in current environment, says Piper Sandler
- 02/08/23 Evercore ISI
- Oak Street Health downgraded to In Line from Outperform at Evercore ISI
BNRE Brookfield Reinsurance - 09/12/22 Compass Point
- Argo Group upgraded to Buy at Compass Point after strategic transactions
- 09/12/22 Compass Point
- Argo Group upgraded to Buy from Neutral at Compass Point
- 08/10/22 Raymond James
- Argo Group downgraded to Market Perform from Outperform at Raymond James
- 08/09/22 Compass Point
- Argo Group downgraded to Neutral from Buy at Compass Point
- 01/31/23 Mizuho
- Mizuho 'constructive' on Uber shares into Q4 results
- 01/30/23 MoffettNathanson
- Uber initiated with an Outperform at MoffettNathanson
- 01/26/23 TD Cowen
- Uber price target lowered to $66 from $70 at Cowen
- 01/24/23 KeyBanc
- KeyBanc upgrades Lyft on 'meaningful opportunity' for EBITDA lift
- $1,627.11 /
-93.35 (-5.43%) - 02/08/23 RBC Capital
- Chipotle price target lowered to $1,850 from $1,900 at RBC Capital
- 02/08/23 Truist
- Chipotle price target lowered to $1,800 from $1,825 at Truist
- 02/08/23 TD Cowen
- Chipotle price target raised to $2050 from $1950 at Cowen
- 02/08/23 Credit Suisse
- Chipotle price target raised to $2,050 from $1,950 at Credit Suisse
- 02/08/23 Morgan Stanley
- Discover downgraded to Equal Weight from Overweight at Morgan Stanley
- 02/08/23 Morgan Stanley
- American Express upgraded to Overweight from Equal Weight at Morgan Stanley
- 02/01/23 Citi
- Citi sees weakness in Synchrony after CFPB proposal as buying opportunity
- 02/01/23 BTIG
- CFPB credit card late fee proposal 'more onerous than expected,' says BTIG
- 01/24/23 Citi
- Discover price target raised to $118 from $113 at Citi
- 01/20/23 BMO Capital
- Discover price target lowered to $111 from $119 at BMO Capital
- 02/08/23 BofA
- TripAdvisor upgraded to Buy from Underperform at BofA
- 12/07/22 Wolfe Research
- TripAdvisor downgraded to Underperform from Peer Perform at Wolfe Research
- 11/25/22 DA Davidson
- TripAdvisor price target lowered to $30 from $33 at DA Davidson
- 11/09/22 Wells Fargo
- TripAdvisor price target lowered to $22 from $30 at Wells Fargo
- 02/08/23 Credit Suisse
- United Rentals initiated with an Outperform at Credit Suisse
- 01/31/23 Argus
- United Rentals price target raised to $475 from $360 at Argus
- 01/27/23 Deutsche Bank
- United Rentals price target raised to $399 from $341 at Deutsche Bank
- 01/27/23 Stifel
- United Rentals price target raised to $505 from $450 at Stifel
- 01/11/23 Barclays
- Alibaba price target raised to $141 from $114 at Barclays
- 01/10/23 Citi
- Alibaba price target raised to $160 from $144 at Citi
- 01/09/23 Morgan Stanley
- Alibaba price target raised to $150 from $100 at Morgan Stanley
- 01/08/23 Goldman Sachs
- Alibaba upgraded to Conviction Buy from Buy at Goldman Sachs
WBD Warner Bros. Discovery - 01/31/23 Macquarie
- Warner Bros. Discovery price target raised to $20 from $16 at Macquarie
- 01/30/23 Morgan Stanley
- Warner Bros. Discovery price target raised to $17 from $14 at Morgan Stanley
- 01/24/23 Atlantic Equities
- Atlantic sees 80% upside in Warner Bros. Discovery after analyzing merger
- 01/11/23 Guggenheim
- Guggenheim upgrades Warner Bros. Discovery to Buy, sees 31% potential upside
- 02/02/23 Citi
- Citi ups GM target, reiterates as top pick post results
- 02/01/23 Deutsche Bank
- General Motors price target raised to $36 from $33 at Deutsche Bank
- 02/01/23 Morgan Stanley
- General Motors price target raised to $35 from $32 at Morgan Stanley
- 02/01/23 BofA
- General Motors price target lowered to $70 from $80 at BofA
- 02/06/23 RBC Capital
- RBC downgrades Vale, says shares 'moved past fair value'
- 02/06/23 RBC Capital
- Vale downgraded to Sector Perform from Outperform at RBC Capital
- 12/09/22 Morgan Stanley
- Vale upgraded to Overweight from Equal Weight at Morgan Stanley
- 12/08/22 BMO Capital
- Vale price target raised to $20 from $16 at BMO Capital
- 01/27/23 Morgan Stanley
- Credit Suisse resumed with an Equal Weight at Morgan Stanley
- 01/13/23 Barclays
- Credit Suisse price target lowered to CHF 2.90 from CHF 4 at Barclays
- 01/13/23 Deutsche Bank
- Credit Suisse reinstated with a Hold at Deutsche Bank
- 12/20/22 Exane BNP Paribas
- Credit Suisse resumed with an Underperform at Exane BNP Paribas
- 02/08/23 Baird
- Google in good position to be net benefciary of Gen-AI, says Baird
- 02/07/23 Wedbush
- Microsoft set to unveil ChatGPT partnership as AI arms race begins, says Wedbush
- 02/03/23 JPMorgan
- Alphabet price target raised to $118 from $115 at JPMorgan
- 02/08/23 Loop Capital
- Alphabet price target raised to $125 from $120 at Loop Capital
- $77.16 /
+12.46 (+19.26%) - 02/08/23 Truist
- New Relic price target raised to $65 from $55 at Truist
- 02/08/23 RBC Capital
- New Relic price target raised to $75 from $55 at RBC Capital
- 02/08/23 Credit Suisse
- New Relic price target raised to $90 from $78 at Credit Suisse
- 02/08/23 Wedbush
- New Relic price target raised to $75 from $68 at Wedbush
- $24.01 /
+2.945 (+13.98%) - 12/09/22 Deutsche Bank
- Manchester United downgraded to Hold from Buy at Deutsche Bank
- 11/23/22 Jefferies
- Jefferies expects 'competitive process' for Manchester United
- 06/02/22 Deutsche Bank
- Manchester United undervalued after selloff, says Deutsche Bank
- 03/21/22 Deutsche Bank
- Manchester United upgraded on 'value disconnect' at Deutsche Bank
- $15.90 /
+2.325 (+17.13%) - 01/12/23 Susquehanna
- Kyndryl Holdings initiated with a Neutral at Susquehanna
- 12/15/22 JPMorgan
- Kyndryl Holdings price target raised to $13 from $11 at JPMorgan
- 08/02/22 JPMorgan
- Kyndryl Holdings initiated with a Neutral at JPMorgan
- $41.43 /
+4.775 (+13.03%) - 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 08/04/22 Morgan Stanley
- New York Times price target lowered to $37 from $40 at Morgan Stanley
- 07/21/22 Guggenheim
- New York Times price target lowered to $34 from $41 at Guggenheim
- 02/08/23 Citi
- Lumen downgraded to Sell from Neutral at Citi
- 12/06/22 Goldman Sachs
- Lumen reinstated with a Neutral at Goldman Sachs
- 11/14/22 Wells Fargo
- Dycom price target lowered to $120 from $130 at Wells Fargo
- 11/03/22 UBS
- Lumen price target lowered to $7 from $11 at UBS
- $24.38 /
-3.305 (-11.94%) - 01/13/23 B. Riley
- Xponential Fitness price target raised to $32 from $30 at B. Riley
- 01/10/23 Baird
- Xponential Fitness price target raised to $32 from $30 at Baird
- 12/06/22 Citi
- Xponential Fitness initiated with a Buy at Citi
- 11/18/22 Baird
- Xponential Fitness price target raised to $30 from $26 at Baird
- 02/06/23 Deutsche Bank
- Under Armour price target raised to $14 from $11 at Deutsche Bank
- 01/23/23 JPMorgan
- Under Armour price target raised to $13 from $11 at JPMorgan
- 12/22/22 William Blair
- Linnartz an 'interesting choice' to head Under Armour, says William Blair
- 12/12/22 Stifel
- Under Armour upgraded to Buy from Hold at Stifel
- 01/17/23 Exane BNP Paribas
- Under Armour upgraded to Outperform from Neutral at Exane BNP Paribas
- 12/23/22 Wells Fargo
- Under Armour price target lowered to $14 from $20 at Wells Fargo
- 02/08/23 Deutsche Bank
- Fortinet price target raised to $63 from $53 at Deutsche Bank
- 02/08/23 RBC Capital
- Fortinet price target raised to $68 from $57 at RBC Capital
- 02/08/23 Stifel
- Fortinet price target raised to $72 from $64 at Stifel
- 02/08/23 Roth MKM
- Fortinet price target raised to $70 from $65 at Roth MKM
- 02/08/23 Deutsche Bank
- VF Corp. price target lowered to $33 from $35 at Deutsche Bank
- 02/06/23 BTIG
- VF Corp. assumed with a Neutral at BTIG
- 02/06/23 Deutsche Bank
- Deutsche Bank lowers VF Corp. price target to $35 ahead of quarterly results
- 01/24/23 Baird
- VF Corp. downgraded to Neutral from Outperform at Baird
- $48.59 /
-17.68 (-26.68%) - 01/31/23 Citi
- Capri Holdings price target raised to $75 from $67 at Citi
- 01/23/23 JPMorgan
- Capri Holdings price target raised to $70 from $66 at JPMorgan
- 01/23/23 Barclays
- Capri Holdings price target raised to $72 from $56 at Barclays
- 12/20/22 Raymond James
- Capri Holdings initiated with an Outperform at Raymond James
- 01/18/23 Baird
- Aspen Technology price target lowered to $224 from $242 at Baird
- 01/17/23 Deutsche Bank
- Emerson makes hostile bid for National Instruments, says Deutsche Bank
- 01/09/23 Citi
- Citi opens 'positive 90-day catalyst watch' on Rockwell Automation
- 01/04/23 UBS
- Emerson Electric downgraded to Neutral from Buy at UBS
- $24.38 /
-3.305 (-11.94%) - 01/09/23
- Xponential Fitness expects to meet or exceed high end of FY22 outlook
- 11/10/22
- Xponential Fitness raises FY22 revenue view to $235M-$240M from $211M-$221M
- 11/10/22
- Xponential Fitness reports Q3 adjusted EPS 10c, consensus 14c
- 08/11/22
- Xponential Fitness raises FY22 revenue view to $211M-$221M from $201M-$211M
WBD Warner Bros. Discovery - 11/03/22
- Warner Bros. Discovery reports Q3 EPS (95c), consensus (21c)
- 11/03/22
- Warner Bros. Discovery reports Q3 revenue $9.82B, consensus $10.36B
- 11/03/22
- Notable companies reporting after market close
- 02/07/23
- VF Corp. sees FY24 operating earnings up double-digits
- 02/07/23
- VF Corp. sees FY23 adjusted EPS $2.05-$2.15 vs. prior $2.00-$2.20
- 02/07/23
- VF Corp. reports Q3 adjusted EPS $1.12, consensus 98c
- 01/25/23
- United Rentals sees FY23 revenue $13.7B-$14.2B, consensus $13.46B
- 01/25/23
- United Rentals reports Q4 EPS $9.15, consensus $10.37
- 10/26/22
- United Rentals raises 2022 revenue outlook to $11.5B-$11.7B from $11.4B-$11.7B
- 10/26/22
- United Rentals reports Q3 EPS $9.27, consensus $9.06
- 02/08/23
- Uber reports Q4 EPS 29c, consensus (18c)
- 02/07/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- Uber reports Q3 EPS (61c), consensus (22c)
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 11/07/22
- TripAdvisor sees Q4 revenue of low-single digit increases from 2019 levels
- 11/07/22
- TripAdvisor reports Q3 adjusted EPS 28c, consensus 38c
- 01/09/23
- Oak Street Health sees FY23 revenue $3.0B-$3.15B, consensus $3.05B
- 01/09/23
- Oak Street Health raises FY22 revenue view to at or above $2.155B
- 11/07/22
- Oak Street Health reports Q3 EPS (56c), consensus (61c)
- $41.43 /
+4.775 (+13.03%) - 02/08/23
- New York Times reports Q4 adjusted EPS 59c, consensus 43c
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- $77.16 /
+12.46 (+19.26%) - 02/07/23
- New Relic sees Q4 adjusted EPS 20c-23c, consensus 15c
- 02/07/23
- New Relic sees FY23 adjusted EPS 40c-43c, consensus 19c
- 02/07/23
- New Relic reports Q3 adjusted EPS 32c, consensus 15c
- 11/08/22
- New Relic sees Q3 adjusted EPS 14c-17c, consensus 14c
- $268.58 /
+1.005 (+0.38%) - 01/24/23
- Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29
- 01/24/23
- Notable companies reporting after market close
- 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
- $24.01 /
+2.945 (+13.98%) - 12/08/22
- Manchester United reports Q2 adjusted EBITDA GBP 23.6M vs. GBP 11.2M y/y
- 09/22/22
- Manchester United sees FY23 revenue GBP 580M-GBP 600M
- 09/22/22
- Manchester United reports Q4 adjusted EPS (GBP 12.38) vs. (GBP 20.67) last year
- 02/07/23
- Lumen sees FY23 adjusted EBITDA $4.6B-$4.8B
- 02/07/23
- Lumen reports Q4 adjusted EPS 43c, consensus 19c
- 11/02/22
- Lumen reports Q3 adjusted EPS 14c, consensus 37c
- $15.90 /
+2.325 (+17.13%) - 02/07/23
- Kyndryl sees FY23 revenue $16.8B-$17B, consensus $16.45B
- 02/07/23
- Kyndryl reports Q3 EPS (47c), consensus (82c)
- 02/02/23
- Alphabet reports Q4 EPS $1.05, consensus $1.18
- 02/02/23
- Notable companies reporting after market close
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 01/31/23
- General Motors sees FY23 adjusted EPS $6.00-$7.00, consensus $5.81
- 01/31/23
- General Motors reports Q4 adjusted EPS $2.12, consensus $1.69
- 01/30/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Fortinet sees FY23 EPS $1.39-$1.41, consensus $1.39
- 02/07/23
- Fortinet sees Q1 EPS 27c-29c, consensus 27c
- 02/07/23
- Fortinet reports Q4 EPS 44c, consensus 39c
- 02/08/23
- Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08
- 02/08/23
- Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00
- 02/08/23
- Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c
- 10/31/22
- Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08
- 01/18/23
- Discover reports Q4 EPS $3.77, consensus $3.66
- 01/18/23
- Notable companies reporting after market close
- 10/24/22
- Discover Financial reports Q3 EPS $3.54, consensus $3.72
- 10/24/22
- Notable companies reporting after market close
- 02/08/23
- CVS Health sees FY23 revenue $332.7B-$338.5B, consensus $325.11B
- 02/08/23
- CVS Health reports Q4 adjusted EPS $1.99, consensus $1.92
- 02/08/23
- CVS Health sees FY24 adjusted EPS $9.00, FY25 adjusted EPS $10.00
- 02/08/23
- CVS Health backs FY23 adjusted EPS view $8.70-$8.90, consensus $8.86
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- $48.59 /
-17.68 (-26.68%) - 02/08/23
- Capri Holdings sees Q4 EPS 90c-95c, consensus $1.39
- 02/08/23
- Capri Holdings sees FY23 adjusted EPS $6.10, consensus $6.87
- 02/08/23
- Capri Holdings reports Q3 adjusted EPS $1.84, consensus $2.22
- $1,627.11 /
-93.35 (-5.43%) - 02/07/23
- Chipotle reports Q4 adjusted EPS $8.29, consensus $8.90
- 02/07/23
- Notable companies reporting after market close
- 10/25/22
- Chipotle reports Q3 adjusted EPS $9.51, consensus $9.21
- 10/25/22
- Notable companies reporting after market close
- 11/17/22
- Alibaba reports Q2 adjusted EPS $1.82, consensus $1.64
- 11/16/22
- Notable companies reporting before tomorrow's open
- 01/27/23
- American Express reports Q4 EPS $2.07, consensus $2.22
- 01/26/23
- Notable companies reporting before tomorrow's open
- 10/21/22
- American Express sees FY22 EPS above $9.25-$9.65, consensus $9.91
- 02/06/23
- Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51
- 02/06/23
- Notable companies reporting after market close
- 11/07/22
- Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c
- 11/07/22
- Notable companies reporting after market close
- 11/07/22
- Argo Group reports Q3 operating EPS 44c, consensus ($2.20)
- 08/08/22
- Argo Group reports Q2 operating EPS 89c vs $1.60 last year
|
